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INTRODUCTION 
 
 The Siddha system of Medicine is the ancient medicinal system.in the 
world. Siddha medicine is the earliest medicine ever documented in the world 
and the oldest medical system in existence. Siddha system of medicine can be 
considered as the crown of all the traditional arts of the ancient world owing to 
its richness and simplicity. 
 Siddhars are saints who attained Ashtama Siddhis which means eight 
super natural powers. Siddhis are acquired constant practice of certain yogic 
disciplines. Through their practices they are believed to have reached stages of 
insight which enabled them to tune into the powers hidden in various material 
substances and practices, useful for suffering and ignorant mankind.  
 Siddhars define health as a perfect state of physical, psychological, social 
and spiritual well being of an individual. Siddhars were of the concept that a 
healthy soul can only be developed through a healthy body. So they developed 
methods and medications that are believed to strengthen their physical body 
and mind 
 The human body is a composite of three humours such as vaatham, 
pittham and kabam and seven thathus such as saram, senneer, oon, 
kozhluppu, enbu, moolai and sukkilam. According to Siddha medicine various 
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psychological and physiological functions of the body are attributed to the 
combination of seven elements. The evenness of humours, body tissues and 
waste products is studied as health and its imbalance, may leads to disease 
when the normal equilibrium of the three humours (vaatham, pittham and 
kabam) is disturbed disease is caused. 
 The Siddhars classified the disease into 4448 types. One among the 
diseases which comes  under the  disorder  of the  Urinary  system  or visarka 
urupugal is KALLADAIPPU NOI. In modern system of medicine, KALLADAIPPU 
NOI is similarly compared and corelated in modern science as Urolithiasis. 
 Urinary stone constitutes one of the most common diseases in our 
country and pain due to Kidney stone is known to be the worst pain compared 
to any other pain. In India approximately 5-7 million patients suffer from stone 
disease and atleast 1/1000 of Indian population needs hospitalisation due to 
Kidney stone disease. 12% shave stone in than life time. 12% of men will suffer 
from kidney stone by age 70. 5% of women will suffer from kidney stone by age 
of 70. The problem  of Urinary calculi is more common in males than in 
females. The highest incidence of kidney stone is in 30-45 years of age group 
and the incidence declines after the age of 50. 
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The disease of Urinary system is classified into : 
1. Neerinai arukkal noigal 
2. Neerinai perukkal noigal 
 In YUGI VAITHIYACHINTHAMANI - 800, Part II, KALLADAIPU NOI comes 
under Neerinai arukkal noigal. Kidney stones are small solid masses formed 
when salts and minerals normally found in Urine become solid crystals inside 
the kidney. The stones are made up of the concentrate of substances usually 
found in Urine. The size of the stones may vary from sand / gravel to the size of 
a bird’s egg. 
 Several drugs are available for treating KALLADAIPPU NOI in Siddha 
medicine system. It is evident from Siddha literature that therapeutic value of 
several drugs have been proved. However, clinical  trials on the treatment of 
KALLADAIPPU NOI have not yet been undertaken for the medicine ARUVAGAI 
CHOORANAM (internal) mentioned in the text Brahmamuni vaidhya soothiram 
- 360, Part - I, Page No.120. Hence this Siddha medicine has been chosen for 
my dissertation work to evaluate its therapeutic values in treating 
KALLADAIPPU NOI through clinical studies. 
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AIM AND OBJECTIVES 
 
 Renal Calculus is one of the most common disorders of the Urinary tract 
and most painful condition of the Urological disorders. There is no specific 
internal medicine for Renal Calculus in Modern Medicine. Only surgical 
procedures are performed to remove stones. Several Siddha literatures deal the 
origin of the disease and its treatment. Various preventive and curative 
treatments are found in Siddha literatures. Hence the disease KALLADAIPPU 
NOI has been taken for the present study and a Siddha medicine such as 
ARUVAGAI CHOORANAM (internal) has been selected from the literature for 
evaluating their efficacies in treating KALLADAIPPU NOI. 
General objective 
 To evaluate the efficacy of the trial internal medicine ARUVAGAI 
CHOORANAM.  
Specific objectives 
1. To select the KALLADAIPPU NOI patients according to aetiology and 
clinical features revealed in Siddha literatures and compared with 
modern science. 
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2. To investigate Siddha fundamental and modern parameters during and 
after treatment in all selected patients. 
3. To perform Urine analysis, haematological studies and Ultra sonography 
for all patients. 
4. To perform stone analysis in selected cases. 
5. To undertake biochemical and microbiological analysis of the trial 
medicine 
6. To evaluate pharmacological actions such as urolithiatic and diuretic 
activities of the trial medicines. 
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ABSTRACT 
 
 Kalladaippu Noi is one of the most common and excruciating painful 
disease. The symptoms associated with Kallaidappu are renal colicky pain in 
loin, renal angle and lower abdomen. Pain radiating from loin to groin, thigh 
and external genetalia, abdominal distention, burning mixturation, anueria, 
oliguria, concentric urination, haematuria, pyuria, Nausea, Vomiting, fever, 
chills and sweating. In india approximately 5 to 7 million patients suffering 
from renal stone disease and atleast 1/1000 of indian population needs 
hospitalization due to renal calculas diseases. Hence this disease kallaidaippu 
was choosen for my disseatation work. 
 The inscriptions mentioned in the siddha literatures about the causes, 
types, symptoms and therapeutics of kalladaippu noi were informative and 
impressive.  
 A drug which correct crystalloid colliod imbalance and relieves the 
binding mucin of calculi, antispetic, antisposmadic and diuretic, should relax 
the detrusor muscle of urinary bladder and prevent the super saturation of 
crystalloid may have the roll in the management of urinary calculi. In siddha 
texts so many combination of drugs having all these properties are described 
treating kalladaippu noi. However clinical trials on the treatment of 
kalladaippu noi have not been undertaken for the medicine Aruvagai 
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chooranam (Internal) Brahmmamuni vaidya soothiram - 390, Part -I Page 
no.120. Hence these medicine has been choosen for the dissertation work to 
evaluate the therapeutic value in treating Kalladaippu noi in clinical study. 
 The disease was diagnosed by following various siddha diagnostic 
methods like Envagai Thervugal, Mukkutra Verupadugal, Neerkuri and Neikuri 
and Modern diagnostic methods that included laboratory, radiological and 
sonological investigations. A total of 40 patients of either sex (20 OP and 20 IP) 
were selected and administered with the following trial medicine at PG 
Department of Pothu Maruthuvam,Government Siddha Medical College and 
Hospital, Palayamkottai as below: 
 Aruvagai Chooranam - 2 gm BD Morning and Evening  with  
   Hot water after food 
 The trial medicine is analysed biochemically, microbiologically and 
pharmacologically. The biochemical analysis of trial medicine revealed the 
presence of various types of minerals and the microbiological analysis revealed 
the antibacterial Activity of the trial medicine. The pharmacological study 
revealed the litho triptic, diuretic and anti-spasmodic effect of the trial 
medicine. Ultra sonographic investigations were carried out for all the patients 
before the treatment to confirm the diagnosis of kalladaippu noi, revealed 
clinically,   pathologically, biochemically and through microscopic examination. 
USG investigations done at the end of the treatment revealed good response of 
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the trial medicines in treating Kalladaippu noi in 80 % of OP and 65% of IP and 
moderate response in 15% of OP and 35% of IP.  Hence, it can be concluded 
that the trial medicine, Aruvagai Chooranam (Internal) is highly effective and 
economically viable in curing Kalladaippu noi. 
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REVIEW  OF  LITERATURES 
SIDDHA ASPECTS 
 
 The Siddha system of medicine is considered to be the ancient traditional 
medicinal system in the world. Siddha literatures classified 4448 various 
diseases, that include aetiology, diagnosis, treatment, medicines, diet and 
prevention. Among the various diseases, ‘Kalladaippu Noi’’ is one of the most 
common disease in India. Several preventive and curative treatments are found 
in various siddha literatures for Kalladaippu noi. The most prominent and 
ancient siddha literature is  “Yugi Vaithya Chinthamani -800”.  
 The Kalladaippu noi is one among the ‘Neerinai Arukkal Noikal’ which is 
an evident from the following poem mentioned in the ancient siddha literature, 
“Theran Karisal” 
  “¨Ãì Åû]d áQjûR 
  ¨VÈ ÅÃjçf ùNôpYôm 
  ¨Ãû]l ùTìdLùXôuú\ 
  ¨Ãû] VìdL ùXôuú\ 
  ¨ÃÆîPú] ùLôpím 
  ¨odLhå Åû]Lù[ôuñ” 
- úRWu LÃNp 
úSônSôPp úSôn êRpSôPp-2mTôLm,Td.420 
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1. Verupeyar (Synonyms) 
 Ashmari Rogam 
2. Eyal (Definition) 
 The Kalladaippu noi has been defined differently by various authors.  
i) In “Agathiyar Gunavagadam”, Kalladaippu noi is defined as  
below:   
 “Rôù]u\ Øj¾Wj¾p S\S\ùYuñ 
  Re¸VúRôo ùTô¼ùVòm UQpRô]lTô 
 Yôù]u\ ºÈVùRôì LpXôYRlTô 
  Y[UôL YkçÅïm úSôndáj Rôú] 
 Hù]u\ AvUÃ úWôLùUu\ úTWôm 
  GÇRôLd LpíLsRôu ÅïámúTôç 
 úLôù]u\ ái¼dLôn Øj¾WdáZXlTô 
  áQUô] Øj¾WlûT ¨oRôûWd úLú[“ 
 “úL[Pô êuáÈÂp GÃfNp Liå 
  ùL¼VôL úYRû]Ls LôhåUlTô 
 Yô[Pô ºÈVùRôì LtLsRôú] 
  Y[Uô] Øj¾WlûT áZp YÆlT¼Vônj 
 úR[Pô YìmúTôç ¾úWLkRuÉp 
  ùRÃlTçúTôX ÂìúYRû] ùNnÙmTôì 
 Sô[Pô LtLsRô É\e¸ÅhPôp 
  SXUô] úYRû]LsRôu §ìmTôúW”. 
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 - ALj¾Vo áQYôLPm 
 The above poem written by Agathiyar, defines Kalladaippu noi as 
“deposition of sand-like grains in urine, which results in formation of small size 
stones, followed by expulsion of stones along with urine”. Further, he explained 
that the stones obstruct in the kidney, ureter, urinary bladder and urethra. 
When the stones pass from kidney to ureter, agonizing pain starts and 
intensifies.  While stones reaching the urethral orifice, intense burning 
sensation in glanspenis occurs.  Then the stones get expelled and pain is 
relieved.  
ii) In “T.V.Sambasivam Pillai Agarathi”, Kalladaippu noi is defined as: Large 
concentration of stone in the bladder or kidney produces calculus or 
gravel. It causes difficutly in passing urine. 
iii) In Siddha Maruthuvam, Kalladaippu noi is defined as:  Sudden 
obstruction of flow of urine during micturation, pain in the tip of the penis 
in male and clitoris in female, burning sensation in urethral orifice, pain 
radiating from loin to groin, presence of sand-like stones in the urine are 
the cardinal symptoms of this disease. 
iv) Roga Nirnaya Saaram under Roga nithanam,  Kalladaippu noi is defined 
as: Pain in and around the umbilicus, dysuria, urine odours like goat’s 
urine, fever, chills and anorexia are common features of this disease.  
Noi varum vazhi (Aetiology) 
 The causes of the disease mentioned in various siddha literature are as 
follows. 
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 “ùRÇkRúRôo LpXûPlé EtTj¾ úL[ôn 
  ºÈçSôh ùPôPe¸úV úULk RuÉp 
 RÇkRúRôo NXlûTÂ í¾Wk úRônkç 
  NkRNj RôLúY Tìjçd ùLôsðm 
 YÇkRúRôo YôRÀjRe úLôÀj RdLôp 
  YkçùTìe LpXôn¨o YÆV ûPjç 
 SÇkúRôo SôíÅRd LpX ûPlé 
  SiTô] YWXôñ SôhPd úLú[”  Tô.725, Td-283 
  
 “LXe¸]úRôo Ri¦oRôu á¼jR úTodáe 
  LpùXímé UÂoUiRôu LXkRu ]j¾p 
 AXe¸]úRô Wu]L [ìkR Xôím 
  AïLúXôå ØjRTiP UìkR Xôím 
 UXe¸]úRôo UôlTiP UìkR Xôím 
  UkRj¾p YônYô] TRôojRk Ruû] 
 çXe¸]úRôo ìºRuÉt ãûYjR Xôím 
  ãìdLôndLp XûPléYkç úRôuñk Rôú]” Tô.727, Td.284 
     - Ù¸ ûYj¾V ºkRôU½-800 
 The above mentioned poems reveal that in the patient suffering from 
chronic mega noi,  the semen stagnates in the urinary tract for a long time, 
leading to the obstruction of the tract. This condition results in the deposition 
of urine constituents and formation of stones in the urinary tract. In mean 
while, due to the increased vatham and pitham, the small stones become large 
in size and obstruct the urinary passage. The formation of urinary stones is 
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also attributed to the drinking contaminated, hard water, consuming food 
adultered with sand and small stones, contaminated food, starchy food and 
unhealthy food habits etc. 
 “¨Ãû] RåjRp ùNnÂu 
  ¨odLhåj çYôWm éiQôm 
 TôÈåg Nkç Nk¾p 
  Tiéñ úSôY Rôám 
 úSÃXe LVìe LôÁVm 
  ¿fNV úSôRp ùNnëm 
 TôÃÉ XTô] Yôë 
  Tié\f úNì Uuú\”. 
- ºjR UìjçYôeLf ãìdLm, Td.198 
 It is inferred from the above poem that when urine is ceased deliberately, 
obstruction of urine flow, sores in the urethral orifice, arthralgia, pain in the 
glanspenis, increased Abaana vayu in the abdomen will result in. 
 “ãdLXk Rû]V Pd¸u 
  ãWêP ²odLh Pôám 
 TdLUôe ûLLôp Nkç 
  TôWúSôn YÆÂ\eám 
 ÁdLUôo úSôëiPôám 
  Áák¾åm ÀWúU LkRôu 
 RdL úRôo úTôçUô¸u 
  RÃj¾åm YôëdÏ ú\”. 
ºjR UìjçYôeLf ãìdLm.Td.212 
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 As per the nature of the body of human beings, semen needs to be 
discharged regularly. In this regard, the above said poem emphasizes that 
delibrate ceasation of seminial discharge results in fever, lumbar pain, oliguria,  
chest pain, arthralgia and white discharge. 
Pothu kuri Kunangal 
The common symptoms of Kalladaippu noi include 
(i) Frequent urination, 
(ii) Suddent obstruction of urine flow, 
(iii) Excruciating pain in the glans penis and anus, 
(iv) Sometimes, when the stone attempts to expel by rolling down, it may not 
be able to expel due to obstruction either in urethra or in the urethral 
orifice. This condition will result in agonizing pain and swelling in the 
Genito-urinary tract. 
(v) When the stones are rough and irregular with sharp projections burning 
sensation and pain will occur in the lower abdomen and urethral orifice. 
Somtimes it may lead to haematuria. 
Noi naadal noi mudal nadal Vol-II. P.427 
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Syndromes associated with Kalladaippu noi 
EdLôWfÑûX 
 ájç êjLôWÑûX Âuá QkRôu 
  úLôoûYVôn ÅXôîRÉp êç¸p ùSgºp 
 Aj¾ ÂÉp SôÀÂX Tô]Uôeá Rj¾p 
  A¾L çuUôe¸NkRôu Y[okç úUÅl 
 TjçUQt TådûLlúTôt NXjç YôWl 
  T¾ùSìd¸ Øj¾WUôe ¸Ãfº ëiPônj 
 RjçNPe LålùTåjç U¾L Xe¸j 
  R[ofº ùVôåUVdLUôLj Rsðk Rôú]”  
Ù¸ ûYj¾V ºkRôU½-800-Tô.233, Td.88 
 This poem reveal that the symptoms of kalladaippu noi include, 
unwanted proliferation of cells in chest, intercostal region, back of trunk, 
umbilicus, anus and urethral orifice, followed by stricture of urethral orifice by 
sand-like crystals, block in the urethra. In addition, dysuria, body pain, 
impairment of consciousness, tiredness and guiddiness also occur. 
Classification 
 There are several types of kidney stones (Urolithiasis). In the siddha 
books, it is evident from various literatures written by siddhars. Some of them 
are given below. 
A. In yugi vaidhya chinthamani-800 
 “úRôuÈPúRôo SôÄÉP SôUe úL[ôn 
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  ãñdLô] YôRj¾u LpX ûPlé 
 ×uÈVúRôo ÀjRj¾u LpX ûPlé   
  éWiPúRôo ºúXhåUj¾u LpX ûPlé 
 §uÈVúRôo ùRôkRUôe LpX ûPlé 
  úRLjûRl TtÈúV ºÈç LôXm 
 RôuÈúV NXlûTÂp Yk¾ Ækç 
  NìÅúV ÄeLj¾t \Ãdák Rôú]” Tô.728, Td.284 
 The above poem mentioned in the Yugi Vaidhya Chinthamani-800, 
classifies  Kalladaippu noi in to four types. They are, 
 i . Vali kalladaippu 
 ii. Azhal kalladaippu 
 iii.  lyya kalladaippu 
 iv. Mukkutra kalladaippu  
i. Vali kalladaippu 
 “RÃjç SôÀdáe ãìdLôn átÈf 
  NXUXkRôu ®ZôUt \mT Uô¸ 
 YÃjçúU ÄeLj¾p YÄë Uô¸ 
  UìÅVúRôo ùTôj¾ùVXôg ãWkç Lh¼ 
 ¾Ãj¾úV ¸ûPdùLôPôl ÀWhPXô¸j 
  úRmÀúV ØfãUôn YÂñ êlém 
 EÃjRúRôo NûRúTôX EYolé Uôám 
  Keá¸VúRôo YôRdLpX ûPlé Rôú]”. Tô.729, Td.284 
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 This poem clearly states that in Vali kalladaippu, patients suffer from 
acute pricking pain in the lower abdomen, scanty micturation, obstruction of 
urine flow, pain in the glans penis making them unable to sit. The other 
symptoms include pain in abdomen, albuminuria, and mucous discharge. 
Finally stone gets expelled along with urine. 
ii. Azhal kalladaippu 
 “AûPlTô¸f NXkRôò UìY Xô¸ 
  AVeLôfºf ùNôì¸]ôt úTôúX Lôæm 
 éûPlTôLl ùTôtÈùVe ámé ïdLUô¸l 
  ×hålúTôp ÀáYô¸l ÀWhP Xôám 
 UûPlTô¸ E¾W¿\ UôndLp Xô¸ 
  Yk¾Ækç ÄeLj¾p Uôh¼d ùLôsðm 
 áûPlTô¸d át\Xônd ÏfN Xô¸d 
  áRhåúU ÀjRdLp XûPlé Rôú]”. Tô.730, Td.285 
 It is evident from the above poem that the cardinal features of Azhal 
kalladiappu include obstruction of urine flow, burning sensation in external 
meatus, acute pain in the urethra and excretion of small blood pigmented 
stones. 
iii.  lyya kalladiappu 
 “Rô]ô ùRôléÇúX Åpí úTôXf 
  NÄVôUt ãWkçúU Ntú\ átñm 
 H]ô] LôúXôå ûLLs Nkç 
  CåléRôu áûPfNXô Âºî Lôæm 
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 úY]ô] ÄeLj¾u ùYiûU RuÉp 
  ÅñÅù\u ú\LålTô¸ ÅVoûY Vôám 
 úR]ô] ùYðlédLp ºñLp XôLf 
  ºdLXôn Yk¾\eág úNhTk Rôú]”.   Tô.731, Td.285 
 This poem clearly mentions that the symptoms of Iyya kalladaippu are 
acute pain and in around the umbilicus, pain radiating towards thigh, joint 
pain, burning micturation, profuse sweating and expulsion of small white 
stones. 
iv. Mukkutra kalladaippu 
 “Yk¾\eám ¨ojRôûW V¼Ât \ôòm 
  UôYìjR êiPô¸ YÄë Uô¸ 
 ùSôk¾\e¸ ¨oRôò UìÅ Tôëm 
  ùSônRô] ºñUQp úTôp ùSôñe¸ LpXôu 
 Nk¾\e¸ ¨oYÆÂp Ykç ®ïm 
  RôdLô] º\eûLdLp ¾]ùUôu ñdá 
 çk¾\e¸j ¾]k¾]ê ÁZkç ùLôpím 
  ùRôkRUôe LpXûPléf Ñh¼h PôúV”.  Tô.732, Td.286 
 The above poem reveals that the patients ailing from Mukkutra 
kalladaippu will suffer from the symptoms like severe burning pain in urethral 
orifice, dysuria, oliguria, expulsion of handful of sand grain like stones with 
urine every day. 
B.In Siddhar Aruvai Maruthuvam 
 Kalladaippu noi is classified into four types 
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i. Vali kalladaippu 
ii. Azhal kalladaippu 
iii. Iyya kalladaippu 
iv. Venneer or Manar kalladaippu 
C. In Thanvanthiri Vaithyam [II part, Page No. (9,10)] 
 “¾ìj¾V YôR ÀjRf ºúXtT]m ÀWúLôÀjRôp 
 YájRã UÃjRô Sôuá YûLlTåm LpXÃlTu 
 ÀÃk¾åg ºúXtT]ôã UÃÀjRô ãUÃ Àuò  
 Áìj¾å ãd¸Xôã UÃSôuá ùUnçùUuú\.” (1) 
 The alteration of three dhoshas results in occurrence of the following four 
types of Ashmari 
 i. Kallarippan 
 ii. Pitha Ashmari 
 iii. Slathma Ashmari 
 iv. Sukkila Ashmari 
i. Kallarippan 
 “ãjç¨o Sô[kRuÉt ãd¸XkRÉt ºúXtT]m 
 ÀjRªçXojRp LpXônl ©N¸¨ WûPjçd ùLôsðe 
 ùLôjç¨ Ãtñ®ïe ùLôlésúSô áPmé Lôëg 
 ºjRô Vìº ëiPôg úNokRLp ùXÃlT]ôúU” (2) 
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 It is learnt from this poem that when kapam and pitham increase, urine 
and semen dry up, resulting in the formation of stone which in turn lead to 
obstruction of urinary tract, dysuria, pricking pain in umbilicus, fever and 
anorexia. 
ii. Slathma  Ashmari 
 “¨o Yì Rô[j RuÉp ¿uñ¨o ºñjçd ùLôiå 
 úNôokRìm ºYlé ùYiûU ãd¸Xm úTôX ®ïm 
 úToùT\ SôXôùUhåm Àu]Uônd Lpí ®ïm 
 HoùTñ ºúXtT]j¾p AfUÃ Gu]XôúU” (3) 
 This poem states that when the calculus arrive the urethral orifice, the 
volume of urine gets reduced gradually, leading to oliguria. Ultimately, the 
stone is broken into four to eight pieces and pass through the urine. 
iii. Pitha Ashmari 
 “ùTnëm¨o Sô[j RuÉp ÀjRjRô ùXÃl ùTïkç 
 ùNnëîx QjRôpùYkç úNeùLôhûP úTôtLp íiPôm 
 SnVúY Rû]Ls ùNnëm SÅp áQm ÀjRkRuÉp 
 GnRã UÃùVuú\êu ÉVmÀ] WÈÅu ÁdúLôo” (4) 
 It is evident from this poem that when pitham accumulates in the 
urethral orifice, severe pain will result in along with burning sensation. This 
condition will lead to formation of calculus of a size of anocardium. 
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iv. Sukkila Ashmari 
 “ãd¸Xm YìeLôXj¾p RmÀjRôt ãd¸XkRôu 
 ÁdLLp Xô¸ùYmÀ ÅR]Uôn ¨oÅPôUt 
 ºd¸¨o ÅZô UXeúL UQp Åïm ùYðdákúRLm 
 ÁdáQg ãd¸Xôã UÃVNôj ¾VùUuú\ôúR” (5) 
 If semen discharge is caesed it gets concentrated and dried up in the 
urethra, preventing the flow of urine which results in anuria. Under this 
condition sand grains like stones pass through the urine and anaemia occur. 
D. In Roga Nirnaya Saaram under Roga Nithanam (Page. 79 & 80)  
Ashmari Rogam is classified into five types as given below. 
i. Vatha Ashmari 
ii. Pitha Ashmari 
iii. Kapa Ashmari 
iv. Sukkila Ashmari 
v. Swargara Ashmari (or) Kalladaippu Rogam 
i. Vatha Ashmari 
 Urine turns to black in colour, dribbling, grunting teeth and rubbing of 
penis. 
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ii. Pitha Ashmari 
 Tip of penis turns to black in colour and urine turning to red, white and 
yellow in colour 
iii. Kapa Ashmari 
 Urine becomes white in colour and highly viscous and flows down like 
honey. 
iv. Sukkila Ashmari 
 Caesation of  seminal discharge during sexual intercourse leads to 
retention of semen in vas defrens or spermaticcord, which get dried up by 
vatham. This condition eventually results in inflammation of testis and lower 
abdominal pain. 
v. Swarkara Ashmari (or) Kalladaippu Rogam 
 Semen is retained in the spermatic region and gets dried up. The dried 
semen turns to stones of  size of sand, green gram, ground nut  and get mixed 
up with urine and pass through the urethral orifice. 
E. In Anubhava Deva Ragasiyam I Part (Page no. 131),  
Ashmari Rogam is classified into five types. 
i. Vatha Ashmari 
ii. Pitha Ashmari 
iii. Kapa Ashmari 
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iv. Sukkila Ashmari 
v. Swarkara Ashmari or Kalladaippu Rogam 
i. Vatha Ashmari 
 Due to increased vatham, rigor, grunting teeth, rubbing of penis and 
umbilicus, crying, vomiting, forced excretion of faeces, dysuria and dribbling of 
black colour urine occur. 
ii. Pitha Ashmari 
 The symptoms include increased temperature in the lower abdomen, 
flatulence, appearance of glans penis as peal of semicorpus anocardium and 
urine turning to red, yellow or white in colour. 
iii. Kapa Ashmari 
 The cardinal features are acute pain in the lower abdomen and urine 
turning to white in colour and highly viscous and flowing down like honey. 
iv. Sukkila Ashmari 
 The symptoms are pain and inflammation in the testis, lower abdominal 
pain, urine taking a long time to get expelled during urination and pain during 
micturation. 
v. Swarkara Ashmari (or) Kalladaipppu Rogam 
 The dried semen is crushed by vatham into small stone of various sizes 
ranging from fine particles of sand or mustard to as large as green gram, or 
bengal gram and even dates which block the passage of urine. If vatham is in 
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normal level, stones will be expelled with urine. When vatham is not in normal 
level, even a drop of urine is not expelled during micturation. 
F. In Sikitcha Rathna Deepam - Vaidhya Chinthamani - II part (Page. 
no.140,141)  
Kalladaippu Rogam is classified into following four types. 
 i. Vatha kalladaippu 
 ii. Pitha kalladaippu 
 iii. Slaethuma kalladaippu 
 iv. Mukkutra kalladaippu 
i. Vatha kalladaippu 
 The symptoms include acute pricking pain in the lower abdomen, 
obstruction of the flow of urine, scanty micturation, pain in the penis, making 
the patient unable to sit, crying, flatulence, presence of albumin in the urine 
and mucous discharge with urine. 
ii. Pitha kalladaippu 
 The symptoms are obstruction of the flow of urine, burning sensation in 
the urethral  orifice  (the burning sensation refers to melting point of iron put 
on the external meatus), acute pain in the urethra and expulsion the small 
blood stained stones. 
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iii. Slaethuma kalladaippu 
 In this kalladaippu, patient suffers from severe pain in the lower 
abdomen, pain radiating towards the thigh,  joint pain associated with rigor 
and pain in the tip of glans penis. Finally, small white coloured stones are 
expelled along with urine.  
iv. Mukkutra kalladaippu 
 Pain in urethral orifice, pain during micturation, presence of small sand 
grain like stones in urine are the cardinal features of Mukkutra kalladaippu. 
6. Mukkutra verupadugal (Pathology) 
 The three uyir thathukkal are formed by combination of  
 Idakalai + Abaanan - vatham 
 Pinkalai + Praanan - Pitham 
 Sulumunai + Samaanan - Kapam 
 Under normal condition, the three factors tend to be in their states of 
equilibrium (1:½:¼) 
 “Et\úRôo EPÄu Ïñ 
 EñléPu ÅWÅ ¿uñ 
 êtñúU úSônLù[pXô 
 ê¾oùT\j úRôuñm úTôç 
 TtñúU YôRÀjR 
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 ºúXtT]k RuÉùXôuû\ 
 TtÈúV úRôuñùUuñ 
 TLokR]o êÉYo Rôú]” 
 - ALj¾Vo áìSô¼-Td-65 
 As per the siddha principles, the manifestation of any diseases is the 
result of disturbed kutrams (ie, vatham, pitham, kapam).   
êdát\ úYñTôåLs 
 EQî, ¨o êRÄVûYL[ôp YÇdát\êm, §dát\êm Áákç EPp ¨ûWf 
ãiPf ùNnç, ºñ¨Ãís[ ElûT ¨odái¼dLôÂp Eû\Vf ùNnç, 
¡rúSôdádLôp (ATô]u) YuûUúVô¼ìkRôp AdLtLû[ GÇ¾p ºñ¨ìPu 
ùYÇúVtÈëm, YuûUVtÈìkRôp LtLû[ AqYlúTôç ùYÇVôdLôç AeLeúL 
ºñ¨o úTôám YÆÂp GeúLòm ReLf ùNnç LpXûPlé úSôûVl À\lÀdám. 
- úSônSôPp úSôn êRpSôPp-TôLm2, Td.-427 
 “YôëÅ]ôúX UXNXe Lh¼åm 
 ÀÃk¾åm ÀjRm úTôWôg NXj¾ÉúX” 
 - ºjRUìjçYôeLf ãìdLm, Td.154  
 The above poem mentioned in Siddha Maruthuvanga Surukkam 
emphasizes that alteration in diet, salt and water intake will lead to alteration, 
mainly increase in vatha and pitha kutram in the body, which in turn result in 
sedimentation of urine in the kidney. Under this condition, if Abaanan is 
favourable, these sedimented deposits get expelled with the urine. If it is 
unfavourable, these deposits do not get expelled with urine. Instead, they get 
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deposited in the urinary tract, which pave way for the occurrence of this 
disease. 
Functions of Mukkutram 
Vatham Pain in the body, twitching pricking pain, inflammation, reddish 
complexion, dryness of skin, hardness of limbs, astringent sense of 
taste in the mouth, unpalatable taste, sweating during sleep, 
traumatic pain, constipation, oliguria, blackish discolouration of 
skin, stool and urine and muddy conjunctiva. 
Pitham Hyperacidity, burning sensation in the stomach, yellowish 
discolouration of skin, eye, urine, sense of defeacation, profuse 
sweating, dizziness etc. 
Kapam Fair complexion, itching, dullness, cold, heaviness, loss of 
sensation, sweetness in mouth, indigestion etc., 
Roles of Mukkutram 
 Abnormal change in these three mukkutram lead to abnormal changes 
in structure, function and behaviour of various body organs.  
Vatham 
 The term vatham denotes vayu, dryness, pain and flatulence.  Based on 
functions and locations, it is classified into the following ten types. They are 
v Piraanan (Uyirkaal) 
v Abaanan (Keezh Nokkukaal) 
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v Viyaanan (Paravukaal) 
v Uthaanan (Melnokkukaal) 
v Samaanan (Nadukkaal) 
v Nagan 
v Koorman 
v Kirugaran 
v Devathathan 
v Dhananjeyan 
 In Kallaidaippu noi, Abaanan was affected by increased urine 
concentration due to stone formation in the urinary pathway which result in 
the obstruction of the flow of urine, scanty micturation, haematuria (due to 
sharp edged stones) and dysuria. When Uthaanan was affected, nausea and 
vomiting will occur.  
Pitham 
 It is the thermal life force of the body. It is subdivided into five types. 
They are,  
v Anarpitham 
v Ranjaga pitham 
v Sathaga pitham 
v Pirasaga pitham 
v Alosaga pitham 
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 In Kalladaippu noi, Sathaga pitham was affected by decrease in urine 
output due to increased pitham and acidic urine. This condition favours the 
formation of stones in the urinary pathway. 
Kapam 
 It is responsible for the streamlined functions of the body and maintains 
body's defence mechanism intact. It is classified into five types as below, 
v Avalambagam 
v Kilethagam 
v Pothagam 
v Tharpagam 
v Santhigam 
 In Kalladaippu noi, Santhigam was affected, patients will not be able to 
walk and move the joints (hip and knee joints) freely. 
UDAL THATHUKKAL 
 When the functional elements (vatham, pitham and kapam) are upset, 
repercussions are felt immediately over the components due to alteration in the 
nature of somatic components. 
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1) Saaram (Digestive essence) 
 It is responsible for the growth and development.   
It keeps the individual in good temperament and enriches the blood. 
 In Kalladaippu noi, Saaram is affected by change in our food habits, 
which result in increase in level of Vitamin.D and become hypervitaminosis. 
Increased Vitamin D is a main cause for Kalladaippu noi (Renal calculi). 
2) Senneer (Blood)  
 It is responsible for the colour of blood and for the intellect, 
nourishment, strength, vigour and valour of the body. 
 In Kalladaippu noi, Senneer is affected. Mean while increased calcium 
and phosphorus level in the blood may cause Kalladaippu noi. 
3) Oon (Muscle)  
 It gives suitable contour to the body, required for the physical activity. It 
feed the fat next day and gives a sort of plumpness to the body. 
 In Kalladaippu noi, Oon is affected. When there is a change in the level of 
vitamins due to change in our food habits. The decrease in vitamin A level may 
lead to destruction and shrinkage of the mucous membrane in the urinary 
tract. Sometimes, damaged mucous membrane get mixedup with urine and 
expelled. 
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4) Kozhuppu (Fat)  
 It lubricates the organs to facilitate frictionless function. 
5) Enbu (Bones)  
 It supports and protects the vital organs, bestows a definite structure to 
the body and is responsible for the posture and movement of the body. 
6) Moozhai (Bone marrow, brain) 
 It nourishes the bone (marrow) and the brain which is the centre that 
controls every other system of the body. 
7)  Sukkilam or Suronitham (Sperm & Ovum) 
 It is responsible for reproduction. 
 In Kalladaippu noi, Sukkilam is affected by the increased body heat and 
hence semen in the spermatic region get dired up and shrunken and become 
small vesicle stones. 
úSôn L½lé êû\ (DIAGNOSIS AND PROGNOSIS) 
 In Piniyari  Muraimai, the following principles are followed in Siddha 
system. They are, 
 1. Poriyaal arithal 
 2. Pulanaal arithal 
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 3. Vinaathal 
 The maruthuvar (physician) should observe the patient, palpate and 
interrogate the patient thoroughly.  
Poriyaal arithal and Pulanal arithal 
 Poriyaal arithal means understanding by the five organs of perception, 
whereas Pulanaal arithal is the understanding by  sensing the objects. They 
are, 
  Mei  - Ooru (Somatic sense) 
  Vaai   - Suvai (Taste) 
  Kan   - Oli (Vision) 
  Mookku - Natram (Smell) 
   Sevi  - Osai (Sound) 
Vinaathal (Interrogation) 
 The first and foremost step in diagnosing a disease is to get to know the 
personal history of the patient through interrogation.  By vinaathal, the 
physician should ask the patients about their native place, socio-economic 
status, food habits, personal habits, complaints and duration of illness etc. 
Poriyaal arithal, pulanaal arithal and vinaathal are applied through eight tools 
of investigation that are “Envagai Thervugal”. 
 Some of the vital aspects of vinaathal are, 
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1) Mukkutra Kaalam (Age distribution) 
 The period of a human life of 100 years is divided into three stages. 
Stage Year Dominant Humor 
First Stage 01 - 33 years Vatha Period 
Second Stage 34 - 66 years Pitha Period 
Third Stage 67 - 100 years Kaba Period 
Thinai (Land) 
 The study of  dwelling places of patients is essential as  the prevalence of 
endemic diseases is very common in certain areas. 
Generally, the Nilam is classified into five. They are, 
1. Kurinji Nilam  Mountain and its surroundings 
2. Mullai Nilam  Forest and its surroundings 
3. Marutha Nilam Fertile plains and their surroundings   
4. Neithal Nilam Seashore and their surroundings  
5. Palai Nilam  Deserts and their suroundings 
 Marutha nilam people are more prone to diseases than other land people, 
as  fertile lands of Maruthanilam is used for industrial purpose which pave way 
for urbanisation and settlement of huge population in smaller area.  
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Paruvakalam (Season) 
 In Siddha system of medicine, Siddhars  classified a year into five 
seasons, each having two months. 
 
 
S.No. Kaalam Kuttram State of Kuttram 1.
 Kar Kaalam (Avani & Purattasi)  Vatham  Vettrunilai valarchi  
 (Aug. 16 - Oct 15) Pitham Thannilai valarchi 
2. Koothir Kaalam (lypasi & Karthigai) Vatham Thannilai valarchi  
 (Oct. 16 - Dec. 15) Pitham Vettrunilai   valarchi 
3. Munpani Kaalam (Margazhi & Thai)  Pitham Thannilai adaithal 
 (Dec. 16 - Feb. 15)   
4. Pinpani Kaalam (Masi & Panguni)  Kapam Thannilai valarchi 
 (Feb. 16 - April 15)    
5. Elavenir Kaalam (Chithirai & Vaikasi)  Kapam Vettrunilai valarchi 
 (Aprl. 16 - June 15)    
6. Mudhu Venir Kaalam (Aani & Aadi)  Vatham Thannilai valarchi 
 (June 16 - Aug. 15) 
Envagai Thervugal 
 “Sô¼vTÃNm Sô¿\m ùUôÆÅÆ 
 UXm Øj¾WÁûY UìjçYWôëRm”  
  -ALj¾Vo Sô¼ 
 The above mentioned poem list out the Envagai Thervugal as below,  
1. Naadi (Pulse)  
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2. Sparisam (Palpation)  
3. Naa (Tongue examination)  
4. Niram (Colour of the body)  
5. Mozhi (Speech)  
6. Vizhi (Eye examination) 
7. Malam (Motion examination) 
8. Moothiram (Urine examination) 
Naadi nadai in Kalladaippu  
 Åïám ºXúSWm ÅåThå ¨úWôåm 
 Jï¸V Yôëîm Jçe¸]ôp úSôLôç 
 Yï¸V UkRjRôp YôëYkúR é¸p 
 LïÁ ê¾ok¾åm LpùXÃlé BáúU 
 - ¾ìØXo Lìd¸ûP ûYj¾Vm - 600 
 When vatham and mantham combine together, Kalladaippu noi occurs. 
 “Aû\kúRômYôR úWô¸ëPp 
  AZtLiêLêm TpUXêm 
 ¿û\kR ÅÆÂp ¨o Y¼ëm 
  ¨iP Sôî Lñj¾Pîm 
 ¾û\kRês[ôn RôÉìdág 
  ºñ ¨o ùTôìÁdLåjç Yìm 
 Eû\kR ¨ìeLìLìjç 
  êû\Vôn úWôLê êiPôúU” 
-ALj¾Vo Sô¼,   
-úSôn SôPp úSôn êRpSôPp ¾Whå-êRpTôLm,Td.165 
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 “úUÅVYôRg ùNnëm 
  áQkRû] ÅìmÀdúLð 
 RôÅV YÂñ UkRg 
  NkçLôp ùTôìjç úSôYôm 
 úNÅV Rôç SôNg 
  ºñjçPu ºñ ¨o®ïm 
 LôÅVe Li½]ôú[ 
  UXUç Lì¸d Lôæm” 
- CWj¾]ãìdL Sô¼ 
-úSôn SôPp úSôn êRpSôPp ¾Whå-êRpTôLm,Td.165 
 Agathiar naadi and Raththina churukka naadi describes that 
aggravation of vatham produces symptoms of Kalladaippu noi. 
 “ùTôì[ô] YôRj¾p ÀjRg úNokç 
  ùTôìjç áQeL[ô êxQ YôëNj¾ 
 ùNÃVôûU éÇjúRlTm ùTôìUp ¨Ãt 
  ºYlé UXm À¼jRíìkRôç ShPm 
 LìYô] úRLU¾íû[fNp úNômTp 
  ûL Lôp RÈlé SôdLNdá Uu]m 
 TÃYô] Üi áû\Rp ìº úLPôRp 
  TX úSôëm Yìj¾ûYdám Tôeá Rôú]” 
- NRLSô¼  
-úSôn SôPp úSôn êRpSôPp ¾Whå-êRpTôLm,Td.171 
 “HYXôn áZXôn ÀjRg ùNnáQm Å[mTdúL[ôn 
 úLôXúYp ÅÆ ºYkç áÇok¾¼Ãìdá UpXôp 
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 £XúY ¨oLåjç ùSôkç ãñdùL]fº Ykç ®ïm 
 OôXúU ¸ñ¸ù\uñ SôîXok¾ìdáeLôúQ”. 
- CWj¾] ãìdL Sô¼ 
-úSôn SôPp úSôn êRpSôPp ¾Whå-êRpTôLm,Td.168 
 The above poem reveals that aggravation of pitham produces the 
symptoms of Kalladaippu noi. 
 “Gi½V YôRùUôuñm ÀjRÁWi ùPïkçRô¸p 
 éiùQ] ëPméúSôYôm éûLùVZ ùVÃëm ùSgã 
 ¾iQUôn SôYWiå ºñjç¨od Låjç Åïm 
 AiQYôo EûWkRîiûU Vôëì úRYkRôú]” 
 - RuYk¾Ã ûYj¾Vm - êRpTôLm Td.11 
 Sathaganaadi and Dhanvanthiri vaidhyam describes, when vatham and 
pitham combine together it results in the occurrence of Kalladaippu noi. 
vTÃNm (Touch) 
 By sparism, the temperature of skin (thatpam-cold or veppam-heat), 
smoothness, roughness, sweating, dryness, hard patches, swelling, abnormal 
growth of organs and tenderness can be felt.  
 On examination in Kalladaippu patients, tenderness over the lower 
abdomen, renal angle and lumbar region can be felt in Kalladaippu noi. In 
Valikalladaippu, swelling can be felt  (may be due to hydronephrosis). 
 In pitha kalladaippu, body temperature  increases in lower abdomen. In 
Iyyakalladaippu, sweating occurs all over the body at the time of colic. 
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Sô  (Tongue)  
 The physician is expected to observe the features of the tongue and its 
associated structures that include colour, size, shape, coating, moisture, 
movement, ulcer, fissures, crust and condition of teeth and gums. In 
Kalladaippu noi, if the patient suffers from constipation (valikalladaippu), the 
tongue would seem to be coated.  
¿\m (Colour) 
 The physician is required to observe the colour of the skin, conjunctiva, 
tongue, nail bed and hair etc and make a note of any abnormal colour changes. 
Normally,  
 Vali udal -  Black colour 
 Azhal udal -  Yellow or red colour  
 lyya udal - White or yellow colour 
 In Kalladaippu noi, body complexion depends upon the body 
constitution. Pallor of the body is observed in Sukkila ashmari. 
 “ºd¸¨o ÅZô UXeúL UQpÅïm ùYðdákúRLm 
 ÁdáQg ãd¸Xôã UÃVNôj ¾VùUuú\ôúRô” 
-RuYk¾Ã ûYj¾Vm,2TôLm-Td.10 
ùUôÆ (Speech) 
 By examining mozhi (speech), characters, hoarseness, slurring speech, 
various disorders of speech such as dysarthria can be noted. In Kalladaippu 
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noi, there is low pitch voice due to agonizing pain in lower abdomen and 
burning micturation. 
 
 
ÅÆ (Eye) 
 The colour of conjunctiva is observed in Kalladaippu noi patients, the 
conjunctiva is pallor due to haematuria. In haematuria may cause secondary 
anaemia. 
UXm (Stools) 
 It is necessary to examine the nature, colour and quantity of stool and  
presence of blood or pus. In Valikalladaippu, proctalgia and oliguria occur due 
to renal colic. 
 “RÃjç SôÀdáe¡r ãìdLôn átÈf 
  NXUXkRôu ®ZôUt \mTUô¸” 
-Ù¸ ûYj¾V ºkRôU½-800-Td.284 
¨odáÈ (Urine examination) 
 Urinary examination is a good diagnostic method compared to Naadi and 
other Envagai Thervugal. Theraiyar mentioned about urine examination as 
below. 
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¨odáÈfº\lé 
 “RodLNôj ¾ÃL [ôú]ôo 
  ReLÇt ú\okç Sô¼ 
 YodLUôm Sô¼ RuÉp 
  YìYç UVdL ùUuú\ 
 Et\¨ol T¬û` VônkúR 
  ëûWjR] ÃRtá úSWôn 
 Utù\ôì Å¾Ö ÄpûX 
  UìjçYd LûXYpúXôodúL” 
 - ºjR UìjçYôeLf ãìdLm, Td.568 
Siruneerin pothugunam 
 “YkR¨od LÃùVûP UQm èûW GgNùXu 
 û\k¾V í[ûY Vû\áç êû\úV” 
 - ºjR UìjçYôeLf ãìdLm, Td.510 
 The above poems states that the five parameters should be examined in 
each urine sample. 
 1. Niram (Colour)  2. Eadai (Specific gravity) 3. Nurai (Froth) 4. Natram 
(Smell) 5. Enjal (Deposits) 
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Niram (Colour) 
Nira Thogai 
 “©Rm ùNmûUûTe LìûU ùYiûUùVu 
 ú\ôûRe ùLôïûUûV ùVôjçá ¨úW” 
 -  ºjR UìjçYôeLf ãìdLm, Td.510 
 They above poem reveals that urine colour may be any one of the 
followings, 
1. Yellow 
2. Red 
3. Green 
4. Black 
5. White 
LpXûPlé ¨Ãu áQm (Colour indicating urinary stones) 
 “§léXôp Lï¨of ùNVùXÉt ái¼d 
 Lônjçol TXjRôp L¾jR ¨WôUj 
 çolTXd LTêm úNôÃëm ùLô¾lé\l 
 TtTL XôLl ûTVl T¾kRúR” 
 - ºjR UìjçYôeLf ãìdLm, Td.520 
 The urine colour resembling the colour of the flesh washed water, 
indicate the occurrence of kidney diseases. (crystaluria) 
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Edai (Specific Gravity) 
 “ÁLjR¼l émÁLj úR\ím Cuù\Ép 
 ãLjûRj RìmùUnf ãTôY¨o Suú\” 
 - ºjR UìjçYôeLf ãìdLm, Td.528 
 Urine which is not thick, is considered healthy. 
Nurai (Froth) 
 “TkRùUnl TûNÂ[ LlTåm TìYj 
 RkRol ×RUôn A¿XØj ¾Wj¾p 
 NmTkRl Tåm R¾èûWl é]úX” 
- ºjR UìjçYôeLf ãìdLm, Td.528 
 Urine is frothy in nature under normal condition. When there is a change 
in vali, azhal, iyyam there will be a change in the frothiness of urine too. 
Naatram (Smell) 
UQÅXdLQm 
 “Lô½¾p £ïe LXk¾Æ UQêÈu 
 LìlTSô ÀLððe LôUSô [jçðm 
 ÅWQêu ¼uú\p GnçUv UÃVX 
 ¾ìjRúX ¾iQ ùU]U]j çuú]” 
 - ºjR UìjçYôeLf ãìdLm, Td.519 
 The above states that foul odour with pyuria is observed in patients with 
urolithiasis assoicted with secondary urinary tract infection and urethral ulcer. 
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Enjal (Deposits) 
 “Sôoj¾ ¨oTôp úTôX 
  SûYët\e ¸Æë Uô]ôp 
 UôWtT êt\ ¨Ã 
  X¼Ui¼d ¸PkR Rô]ôp 
 TôÃkR ùUïá UôeLôn 
  TtÈV LpÄ ]ôúX 
 £ìt\ ùNnûL ùVuñ 
  ùRÃî\f ùNlT XôúU” 
 - ºjR UìjçYôeLf ãìdLm, Td.575 
 In Siddha Maruthuvanga Surukkam the following clinical features have 
been mentioned with regard to Kalladaippu noi. They are, 
i. Pyuria - curd like micturaiton (cloudy urination) 
ii Crystaluria -  sand like deposits  
Neikuri 
 “AìkçUô ÈWRêm AÅúWô RURôn 
  A@Lp AXoRp ALôXÜi RÅokRZt 
 át\[ Yìk¾ E\e¸ ûYLû\ 
  B¼d LXNj RôÅúV LôçùTn 
 ùRôìêÏoj RdLûXd áhTå ¨Ãu 
  ¿\dáÈ ùSndáÈ ¿ìÁjRp LPú]” 
 - ºjR UìjçYôeLf ãìdLm, Td.509 
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Preparation of Patient 
 Prior to the day of urine examination for Neikuri, the patient should be 
advised to take balanced diet and the quantity of food must be proportionate to 
his appetite. In addition, he/ she should have a good sleep.  
Method 
 After waking up in the early morning, urine should be collected in a glass 
container and must be examined within 1½ hours. Then a drop of gingelly oil 
should be added through the side of the container  without any disturbance . 
The nature of neikuri should be noted under direct sunlight. 
Obeservation 
Vatha neer  
 “AWùY] ¨i¼¼u A@úR YôRm” 
 - ºjRUìjçYôeLf ãìdLm, Td.532 
 The drop of oil lengthening  like a snake, it indicates vatha neer. 
Pitha neer  
 “BÆúTôt TWÅu A@úR ÀjRm” 
- ºjRUìjçYôeLf ãìdLm, Td.533 
 The drop of oil spreading like a ring, indicates pitha neer. 
Kapa neer  
 “êjùRôjç ¿t¸u ùUôÆYùRu LTúU” 
- ºjRUìjçYôeLf ãìdLm, Td.534 
 The drop of oil remaining like a pearl, indicates kaba neer. 
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Thontha neer  
 “AWÅXôÆëm BÆÂp AWîm 
 AWÅuêjçm BÆÂp êjçm 
 úRôtÈp ùRôkR úRôPeL[ôúU” 
 The thonthaneer appears as a combination of the above patterns. 
Mukkutra neer  
 The drop of oil immersing in to the urine, indicates mukkutra neer. 
 
NOI KANIPPU VIVAADHAM 
(Differential diagnosis of Kalladaippu) 
¨WûPlé 
 ºñ¨o ãìe¸ A[Åp áû\k¾ÆRím ¨olûTëm ¨oléûZëm, GÃRím YÂñ 
ÅmÁ úSôáRíUô] CVpéûPVç. ¨oléûZÂp, GÃfNp, SûU, úSôRp Guòe 
áÈLû[dLôh¼, ºñ¨o LÆëm úTôç RôeL ê¼VôR GÃfNûXëm úSôûVëk Rkç 
ÑhåPu ¨o C\eám. AlúTôç ¨Ã\eáRtá êuúTòm, ÀuúTòm TfûNd áì¾ 
ùYÇVôám. ºXúYû[ ¨ìPu áì¾ LXkç Lìjç ùYÇVôYçm Eiå. CjçPu 
Cû[lé, ùTìØfã, BVôNm, UôoéúSôn, êL ®dLm, ºñãWm, Cålé úSôn, 
BiáÈ ®dLm, A¼ YÂñ úSôRp, ájRp Guòe áÈ áQeLs CuûUVôím. 
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¨odLhå 
 SôÆ LQdLônf ºñ¨o ùTnVôUúX CìlÀòm, ¨olûT ¿û\Vôç CìjRp, 
¨oléûZ YÆúV NXôûLÂ¼òm ºñ ùNôhå ¨ìm ùYÇVôLô¾ìjRp Guòm 
CVpéûPVRôm. ¨odLhå úSônLÇp, ¨od ái¼dLôëPu ùRôPìm. ¨oléûZLÇp 
Juñ RûPlThå Utù\ôuÈu ùRôÆp ùLPô¾ìlÀu Áá¾ëm úLå 
EiPôY¾pûX. CWiå éûZLðm JúW LôXj¾p AûPTåUôÂu, §ûULs TX 
ùNnëm. ºñ¨o êtÈím LhålThå, ºÈçm C\eLôûU, UVdLm, RûX ãt\p 
Guòm áÈáQeLû[ Lôh¼, ùYá £d¸Wj¾p TådûLÂp ¸PdLf ùNnç, AWhPp, 
éWhPp, ûLLôpL[ ºpÄPp, SôY\hº, ùLôñdáYÄ, LiU½ ãìeLp Guòm 
áÈáQeLs CuûUVôím 
¨ofãìdá 
 ¨õÃû]VìdL ùXuòm ¨odLh¼u áQjûRd úLh¼ 
 ¨RÁp XôUtúLôN ¨oléûZ ùSìlé úTôXôm 
 ¨T]ô ëRjRôt ThP ¨XYm TWôUôe ád¸ 
 G]júRWu LÃNÄp ÏÈVçúTôp, CkúSôÂp ºñ¨o ãìe¸ ùYÇVôLôUím, 
¨oléûZÂp ájRp, GÃfNp YÄ B¸VYtû\ EiPôd¸ëm, êLjûR ®eLf 
ùNnçm, ùNôhå ùNôhPôn ¨Ã\e¸ëm çuéñjçm CVpéûPVRôm. YZdLm úTôp 
¨o NÃVôL C\eLôUp, ÁdL úSWe LÆjç ¨odLÆûLÂp Ak¨o A[Åp áû\kçm 
GûPÂp ãìe¸ëm ¿\j¾p ºYkçm ºXúYû[ éXôp UQjçPu ùYÇlTåm. 
¨oléûZÂp RôeLê¼VôR YÄ, GÃfNp Guòe áÈLû[ EiPôd¸, ¨o ùNôhå 
ùNôhPôn C\eám. CkúSôÂp IVe Ï¼p êLj¾p ®dLêm, CålÀp YÄëm 
HtTåm. 
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 úUtLiP áÈáQeLs CuûUVôím, ºñ¨od LÆdáeLôp A@ç C\e¸d 
ùLôi¼ìdám úTôúR, ¾¥ùW] ¨WûPjRp, áÈêû] úSôRp, ¨oléûZ GÃRp, 
CålÀu Àué\jçm, êçáj Ri¼u TdLjçm úSôRp, ºñ¨Ãp UQûXùVôjR 
ºñLtLs LXk¾ìjRp, êué ÏÈV êtáÈLû[d Lôh¼ A¼dL¼ ùYÇVôám. ¨o 
êtñm ùYÇVôLôUp ¾¥ùW] AûPjçd ùLôsYçm Eiå. AlúTôç RôeLê¼VôR 
YÄ BiáÈÂím GìYôndá úUtTá¾Âím EiPôám. ºX úYû[LÇp Lp 
éWiå ùLôiúP Ykç, ùYÇVôYRtá êVuñ BiáÈ SåÅp ApXç êû]Âp 
Ykç RûPlThå Beá ÁákR YÄûVëm ®dLjûRëm EiPôdám. LtLs 
LWåêWPôúVòm, ÏoûUVôúVòÁìlÀu ¡r YÂtÈím, ¨oléûZÂím 
RôeLê¼VôR GÃfNûXëm YÄûUëm Rkç áì¾ûV ÁLîm ùYÇlTåjçm. 
Nôj¾Vm, ANôj¾Vm (Prognosis)   
 “Ñh¼hP Nôj¾VjûRf ùNôpXd úL[ôn 
  ãðdLôám YôRj¾u LpX ûPlé 
 ×h¼hP ÀjRj¾u LpX ûPlél 
  éLZô] úNhåUj¾u LpX ûPlé 
 Øh¼hP CçØuñ UNôjV Uô¸ 
  êû]Vô] UìkçLÇt ùNmûU Vôám 
 úRôh¼hP ùRôkRUôe LpX ûPléj 
  ùRôåã\úY ùLôpíÁç ÑhNk Rôú]” 
- Ù¸ ûYj¾V ºkRôU½-800 
 According to Yugi Vaidhya Chinthaamani and Siktcharathna Deepam, 
Vatha, Pitha and Kapa  Kalladaippu noi are curable and preventable. 
Mukkutra Kalladaippu is not curable. 
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 According to Roga Nirnaya Saaram under Roga Nithanam, symptoms of 
Kalladaippu noi like scrotal swelling and anuria are not curable.  
UìjçYm (Line of Treatment) 
 The main objective of treatment is to bring down the deranged 
mukkutrams to natural equilibrium by giving purgatives, which cure 
derangement of vatham, which is one of the causes for Kalladaippu noi. 
 “úT¾Vôp YôRm Rôïm” 
 “Yôk¾Vôp ÀjRm Rôïm” 
 “SºV AgN]jRôp LTm Rôïm” 
 As per the above mentioned poem purgation should be given to all 
patients as per their body condition.  
In this present study,   
 Aruvaghai Chooranam - 2 gm (BD Morning & Evening with hot   
 water after food )    
is given to the selected patients which showed good response and in all my 
Kalladaippu noi patients. 
 In Siddha system, treatment is not only for curing the disease but also 
for prevention and improving the body condition after curing the disease. This 
is said as kappu, neekkam and thiraippu. 
 The mode of preparation and properties and constituents of ingredient of 
the drug are given in Annexure-I. 
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Fermentation 
 An attack of renal colic may be aborted by the application of heat 
fermentation (hot water bottle) to the lumbar region. Immediate treatment of 
loin pain or renal colic is bed rest. 
Diet 
 Diet for Kalladaippu Patient 
 áìûY ApXç UQdLjûR AÃºVôXôd¸V úNôñm ês[e¸ (Raphanus 
sativus) ¡ûWjRiå, ºñ¡ûW (Amaranthus gangeticus) YôûZjRiå 
(Plantain stem), AYûW (Dolichos lablab), ùYiûP (Hibiscus esculentas), 
YNûX (Portulacca oleracea) TNûXd¡ûW (Portulacea Pudrifida), LôºÉd¡ûW 
(Hibiscus kannabinus) TôoÄ AÃºdLgº (Parley water) ùLôådLîm. 
 
Diet restriction for Kalladaippu 
 RdLôÇ (Tomato), êhûPúLôv (Cabbage), LôÄ@l[Yo (Cauliflower) 
¨dLîm. Elé ¿û\kR ¨o á¼dLdÏPôç. 
Advice 
1. Patients should drink large quantity of water (4 lit/ day) 
2. Patient should not suppress the excretion of urine and seminal fluid.  
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3. Regarding prevention Anubhava vaidhya deva ragasiyam states that 
one should not suppress the excretion of Moothiram (Urine) and Sukkilam 
(Seminal fluid) is most predisposing cause for Kalladaippu noi. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
 
 
 
 
 
REVIEW OF LITERATURES 
B. MODERN ASPECTS 
 
 
 
 
 
 
67 
 
MODERN ASPECTS  
 
Anatomy and Physiology of Urinary System  
kidney 
 The kidneys are organs that serve several essential regulatory roles in 
most animals, including vertebrates and some invertebrates 
Measurement 
 The kidney is approximately  
 Length 11–14 cm 
 Width  6 cm and  
 Thickness 4 cm . 
Location 
 Located at the rear of the abdominal cavity in the retroperitoneum, 
located between the transverse processes of T12-L3 vertebrae, left kidney 
typically somewhat more superior in position than the right. The upper poles 
are normally oriented more medially and posteriorly than the lower poles. 
 The kidney has a bean-shaped structure; each kidney haa  convex  and  
concavesurface. The concave surface, the renal hilum, is the point at which 
the renal artery enters the organ, and the renal vein and ureter leave. 
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The kidney is surrounded by tough fibrous tissue, the renal capsule, 
which is itself surrounded by perinephric fat, renal fascia and paranephric fat. 
 The anterior (front) border of these tissues is the peritoneum, while the 
posterior (rear) border is the transversalis fascia. 
 The superior border of the right kidney is adjacent to the liver; and 
the spleen, for the left kidney. Therefore, both move down on inhalation. 
 The substance, or parenchyma, of the kidney is divided into two major 
structures: superficial is the renal cortex and deep is the renal medulla.  
 Grossly, these structures take the shape of 8 to 18 cone-shaped renal 
lobes, each containing renal cortex surrounding a portion of medulla called 
a renal pyramid . Between the renal pyramids are projections of cortex 
called renal columns. 
NEPHRON 
 Nephron is the basic structural and functional unit of the kidney. Its 
chief function is to regulate the concentration of water and soluble substances 
like sodium salts by filtering the blood, reabsorbing what is needed and 
excreting the rest as urine.  
 A nephron eliminates wastes from the body, regulates blood 
volume and blood pressure, controls levels of electrolytes andmetabolites, and  
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regulates blood pH. Its functions are vital to life and are 
regulated by hormones such as antidiuretic hormone, aldosterone, 
and parathyroid hormone.  
In humans, a normal kidney contains 800,000 to 1.5 million nephrons.  
The initial filtering portion of a nephron is the renal corpuscle, located in the 
cortex, which is followed by a renal tubule that passes from the cortex deep 
into the medullary pyramids. Part of the renal cortex, a medullary ray is a 
collection of renal tubules that drain into a single collecting duct. 
The tip, or papilla, of each pyramid empties urine into a minor calyx; minor 
calyces empty into major calyces, and major calyces empty into the renal 
pelvis, which becomes the ureter. 
Types of nephrons 
 Two general classes of nephrons are cortical nephrons 
and juxtamedullary nephrons, both of which are classified according to the 
length of their associated Loop of Henle and location of their renal corpuscle. 
All nephrons have their renal corpuscles in the cortex. Cortical nephrons have 
their Loop of Henle in the renal medulla near its junction with the renal cortex, 
while the Loop of Henle of juxtamedullary nephrons is located deep in the renal 
medulla; they are called juxtamedullary because their renal corpuscle is located 
near the medulla The majority of nephrons are cortical. Cortical nephrons have 
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a shorter loop of Henle compared to juxtamedullary nephrons. The longer loop 
of Henle in juxtamedullary nephrons create a hyperosmolar gradient that 
allows for the creation of concentrated urine.  
 Each nephron is composed of an initial filtering component the “renal 
corpuscle” and a tubule specialized for reabsorption and secretion (the “renal 
tubule”). The renal corpuscle filters out large solutes from the blood, delivering 
water and small solutes to the renal tubule for modification 
Renal Corpuscle 
 Composed of a glomerulus and the Bowman’s capsule, the renal 
corpuscle (or Malphigian corpuscle) is the beginning of the nephron. It is the 
nephron’s initial filtering component. 
 The glomerulus is a capillary tuft that receives its blood supply from an 
afferent arteriole of the renal circulation. The glomerular blood pressure 
provides the driving force for water and solutes to be filtered out of the blood 
and into the space made by Bowman’s capsule. The remainder of the blood 
(only approximately 1/5 of all plasma passing through the kidney is filtered 
through the glomerular wall into the Bowman’s capsule) passes into the 
efferent arteriole.The diameter of efferent arteriole is comparatively less than 
that of afferent arteriole, increasing the hydrostatic pressure in the glomerulus. 
It then moves into the vasa recta, which are only found in juxtamedullary 
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nephrons and not cortical nephrons. The vasa recta are collecting capillaries 
intertwined with the convoluted tubules through the interstitial space, in which 
the reabsorbed substances will also enter. This then combines with efferent 
venules from other nephrons into the renal vein, and rejoins the main 
bloodstream. 
 The Bowman’s capsule, also called the glomerular capsule, surrounds 
the glomerulus. It is composed of a visceral inner layer formed by specialized 
cells called podocytes, and a parietal outer layer composed of a single layer of 
flat cells called simple squamous epithelium. 
 Fluids from blood in the glomerulus are filtered through the visceral layer 
of podocytes, and the resulting glomerular filtrate is further processed along 
the nephron to form urine 
 The renal tubule is the portion of the nephron containing the tubular 
fluid filtered through the glomerulus.[5] After passing through the renal tubule, 
the filtrate continues to the collecting duct system, which is not part of the 
nephron 
The components of the renal tubule are: 
 Proximal convoluted tubule (lies in cortex and lined by simple cuboidal 
epithelium with brushed borders which help to increase the area of absorption 
greatly.) 
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 Loop of Henle (hair-pin like i.e. U-shaped and lies in medulla) 
 Descending limb of loop of Henle 
 Ascending limb of loop of Henle 
 The ascending limb of loop of Henle is divided into 2 segments: Lower 
end of ascending limb is very thin and is lined by simple squamous epithelium. 
The distal portion of ascending limb is thick and is lined by simple cuboidal 
epithelium. 
 Thin ascending limb of loop of Henle 
 Thick ascending limb of loop of Henle  
 Distal convoluted tubule 
Blood supply 
 The kidneys receive blood from the renal arteries, left and right, which 
branch directly from the abdominal aorta. Despite their relatively small size, 
the kidneys receive approximately 20% of the cardiac output. 
 Each renal artery branches into segmental arteries, dividing further 
into interlobar arteries which penetrate the renal capsule and extend through 
the renal columns between the renal pyramids. The interlobar arteries then 
supply blood to the arcuate arteries that run through the boundary of the 
75 
 
cortex and the medulla. Each arcuate artery supplies 
several interlobular arteries that feed into the afferent arterioles that supply 
the glomeruli. 
 The interstitum (or interstitium) is the functional space in the kidney 
beneath the individual filters (glomeruli) which are rich in blood vessels. The 
interstitum absorbs fluid recovered from urine. Various conditions can lead 
to scarring and congestion of this area, which can cause kidney dysfunction 
and failure. 
 After filtration occurs the blood moves through a small network of 
venules that converge into interlobular veins. As with the arteriole distribution 
the veins follow the same pattern, the interlobular provide blood to the arcuate 
veins then back to the interlobar veins which come to form the renal vein 
exiting the kidney for transfusion for blood. 
NERVE SUPPLY 
 The kidney and nervous system communicate via the renal plexus, 
whose fibers course along the renal arteries to reach each kidney.  
 Input from the sympathetic nervous system triggers vasoconstriction in 
the kidney, thereby reducing renal blood flow. The kidney also receives input 
from the parasympathetic nervous system, by way of the renal branches of 
Vagus nerve (Cranial nerve X). 
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 Sensory input from the kidney travels to the T10-11 levels of the spinal 
cord and is sensed in the corresponding dermatome. Thus, pain in the flank 
region may actually be referred pain from the corresponding kidney. 
Function of Kidniys 
 Kidneys perform vital functions. By excreting urine, kidneys play 
principal role in the maintenance of internal environment. In addition, kidneys  
perform many other functions as described below. 
Role in homeostasis 
 The primary function of kidneys is homeostasis. It is accomplished by 
the formation of urine. Kidneys are not only the excretory organs, but are also 
the regulatory organs. Their major role is in homeostasis. During the formation 
of urine, kidneys regulate various activities in the body, which are concerned 
with homeostasis. 
i. Excretion of waste products 
 Kidneys excrete the unwanted waste products which are formed during 
metabolic activities. 
 a. Urea  - End product of amino acid metabolism 
 b. Uric  Acid - End product of nucleic acid metabolism. 
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 c. Creatinine - End product of metabolism in muscles. 
 d. Bilirubin - End product of haemoglobin degradation. 
 Kidneys also excrete harmful foreign chemical substances like, toxins, 
drugs, heavy metals, pesticides etc. 
ii. Maintenance of water balance 
 Kidneys maintain the water balance in the body by conserving water 
when it is decreased and excreting  water when it is excess in the body. 
iii. Maintenance of electrolyte balance 
 Maintenance of electrolyte balance, especially sodium is in relation to 
water balance. Kidneys retain sodium if the osmolarity of body water decreases 
and eliminate sodium when osmolarity increases. 
iv. Maintenance of acid base balance 
 The pH of the blood and body fluids should be maintained within normal 
range for healthy living. Body is under constant threat to develop acidosis, 
because of production of lot of acids during metobolic activities. However, it is 
prevented by kidneys, lungs and blood buffers which eliminate these acids. 
Among these organs, kidneys play major role in preventing acidosis. Infact, 
kidneys are the only organs, which are capable of eliminating certain metabolic 
acids like sulphuric and phosphoric acids. 
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2. Haemopoietic function 
 Kidneys stimulate the productions of erythrocytes by secreting 
erythropoietin. Erythropoietin is the important stimulating factor for 
erythropoiesis. Kidneys also secrete another factor called thrombopoietin,  
which stimulates the production of the thrombocytes. 
3. Endocrine  function 
 Kidneys secrete many hormonal  substance in addition to erythropoietin 
and thrombopoietin. The hormones secreted by kidneys includes 
erythropoietin, thrombopoietin, renin, 1,25 dihydroxy cholecalciferol,  
prostaglandins and kinins 
4. Regulation of blood pressure. 
 Kidneys play an important role in the regulation of arterial blood 
pressure. Kidneys  regulate arterial blood pressure by two ways. 
 i. By regulating the volume of extracellular fluid 
 ii. Through renin - angiotensin mechanism 
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Regulation of blood calcium level 
 Kidneys play a key role in the regulation of blood calcium level by 
activating 1, 25-dihydroxy cholecalciferol into vitamin D. Vitamin D is 
necessary for the absorption of cacium from intestine. 
Ureters 
 The ureters are the two tubes which convey the urine from the kidneys 
to the urinary bladder. Each commences within the sinus of the corresponding 
kidney as a number of short cup-shaped tubes, termed calyces, which encircle 
the renal papillæ. Since a single calyx may enclose more than one papilla the 
calyces are generally fewer in number than the pyramids—the former varying 
from seven to thirteen, the latter from eight to eighteen. The calyces join to 
form two or three short tubes, and these unite to form a funnel-shaped 
dilatation, wide above and narrow below, named the renal pelvis, which is 
situated partly inside and partly outside the renal sinus. It is usually placed on 
a level with the spinous process of the first lumbar vertebrae. 
 The ureter descends retroperitoneally on the lateral pelvic wall. At the 
level of the ischial spine, it turns forward and medially. In the male, the ureter 
lies in the sacrogenital fold and is crossed medially by the ductus deferens. In 
the female, the ureter is at first related to the posterior border of the ovary; it 
then lies in the uterosacral ligament and is crossed anteriorly by the uterine 
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artery. It passes about 2 cm lateral to the cervix uteri (and hence may be 
endangered in hysterectomy) and courses in front of the lateral border of the 
vagina. A ureteric stone at this level may even be palpable per vaginam. On 
entering the back of the bladder, the ureter is embedded for about 2 cm in the 
wall of that organ. There the ureteric lumen is narrowest, and the muscular 
coats of the ureter and bladder are continuousThe Ureter Proper measures 
from 25 to 30 cm. in length, and is a thick-walled narrow cylindrical tube 
which is directly continuous near the lower end of the kidney with the tapering 
extremity of the renal pelvis. It runs downward and medialward in front of the 
Psoas major and, entering the pelvic cavity, finally opens into the fundus of the 
bladder. 
 The ureter is composed of three coats: fibrous, muscular, and mucous 
coats. 
 The fibrous coat (tunica adventitia) is continuous at one end with the 
fibrous tunic of the kidney on the floor of the sinus; while at the other it is lost 
in the fibrous structure of the bladder. 
 The muscular coat (tunica muscularis) consists of two layers, 
longitudinal and circular: the longitudinal fibers become lost upon the sides of 
the papillæ at the extremities of the calyces; the circular fibers may be traced 
surrounding the medullary substance in the same situation. In the ureter 
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proper the muscular fibers are very distinct, and are arranged in three layers: 
an external longitudinal, a middle circular, and an internal. 
 The mucous coat (tunica mucosa) is smooth, and presents a few 
longitudinal folds which become effaced by distension. It is continuous with the 
mucous membrane of the bladder below, while it is prolonged over the papillæ 
of the kidney above. Its epithelium is of a transitional character, and resembles 
that found in the bladder  
 The upper half of the ureter is in the abdomen proper; the lower half is in 
the pelvis. 
 The abdominal part (pars abdominalis) lies behind the peritoneum on 
the medial part of the Psoas major, and is crossed obliquely by the internal 
spermatic vessels. It enters the pelvic cavity by crossing either the termination 
of the common, or the commencement of the external, iliac vessels. 
 At its origin the right ureter is usually covered by the descending part of 
the duodenum, and in its course downward lies to the right of the inferior vena 
cava, and is crossed by the right colic and ileocolic vessels, while near the 
superior aperture of the pelvis it passes behind the lower part of the mesentery 
and the terminal part of the ileum. The left ureter is crossed by the left colic 
vessels, and near the superior aperture of the pelvis passes behind the sigmoid 
colon and its mesentery. 
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 The pelvic part (pars pelvina) runs at first downward on the lateral wall 
of the pelvic cavity, along the anterior border of the greater sciatic notch and 
under cover of the peritoneum. It lies in front of the hypogastric artery medial 
to the obturator nerve and the umbilical, obturator, inferior vesical, and middle 
hemorrhoidal arteries. Opposite the lower part of the greater sciatic foramen it 
inclines medialward, and reaches the lateral angle of the bladder, where it is 
situated in front of the upper end of the seminal vesicle and at a distance of 
about 5 cm. from the opposite ureter; here the ductus deferens crosses to its 
medial side, and the vesical veins surround it. Finally, the ureters run 
obliquely for about 2 cm. through the wall of the bladder and open by slit-like 
apertures into the cavity of the viscus at the lateral angles of the trigone. When 
the bladder is distended the openings of the ureters are about 5 cm. apart, but 
when it is empty and contracted the distance between them is diminished by 
one-half. Owing to their oblique course through the coats of the bladder, the 
upper and lower walls of the terminal portions of the ureters become closely 
applied to each other when the viscus is distended, and, acting as valves, 
prevent regurgitation of urine from the bladder. 
Vessels and Nerves 
 The arteries supplying the ureter are branches from the renal, internal 
spermatic, hypogastric, and inferior vesical.  
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 The nerves are derived from the inferior mesenteric, spermatic, and 
pelvic plexuses. 
Constrictions of the ureter 
 There are 3 main constrictions in the ureter  
1. At pelvic ureteric junction 
2. At pelvic brim 
3. Where ureter pierces the bladder wall. 
 Constriction of ureter is important because, some times ureteric calculi 
may cause obstruction at the sites of constrictions of the ureter.  
Urinary bladder 
 The urinary bladder is a musculomembranous sac which acts as a 
reservoir for the urine; and as its size, position, and relations vary according to 
the amount of fluid it contains. 
 The empty bladder in vivo lies almost entirely within the pelvis and rests 
on the pubis and pelvic floor. As the organ fills, it ascends into the abdomen 
proper and may reach the level of the umbilicus. In infancy, however, even the 
empty bladder lies mostly within the abdomen proper.  
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Ligaments 
 The bladder is connected to the pelvic wall by the fascia endopelvina. In 
front this fascial attachment is strengthened by a few muscular fibers, the 
Pubovesicales, which extend from the back of the pubic bones to the front of 
the bladder; behind, other muscular fibers run from the fundus of the bladder 
to the sides of the rectum, in the sacrogenital folds, and constitute the 
Rectovesicales.   
 The vertex of the bladder is joined to the umbilicus by the remains of the 
urachus which forms the middle umbilical ligament, a fibromuscular cord, 
broad at its attachment to the bladder but narrowing as it ascends. 
 From the superior surface of the bladder the peritoneum is carried off in 
a series of folds which are sometimes termed the false ligaments of the 
bladder. Anteriorly there are three folds: the middle umbilical fold on the 
middle umbilical ligament, and two lateral umbilical folds on the obliterated 
hypogastric arteries. The reflections of the peritoneum on to the side walls of 
the pelvis form the lateral false ligaments, while the sacrogenital folds 
constitute posterior false ligaments.   
Relations.  
 The empty bladder is less rounded and is commonly said to have four 
surfaces: superior, right and left inferolateral, and posterior (or base).  
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 The superior surface and the upper part of the base are covered by 
peritoneum. As the bladder fills and ascends, the peritoneum is lifted off the 
abdominal wall; hence the reflection becomes higher. The peritoneal relations 
are important in rupture of the bladder, which may result in either 
intraperitoneal or extraperitoneal extravasation of urine Behind, the 
peritoneum forms the rectovesical (or uterovesical) pouch. The superior surface 
is related to the intestine and the body of the uterus.  
 The inferolateral surfaces are related to the retropubic space, which 
contains veins and a pad of fat. The base faces backward and downward and is 
related to the seminal vesicles, ductus deferentes, and rectum or to the vagina 
and supravaginal cervix.  
 The apex of the bladder is connected to the umbilicus by the median 
umbilical ligament, which is a remnant of the urachus. The bladder is 
connected to the umbilicus also by the right and left medial umbilical 
ligaments, which are the obliterated umbilical arteries. The main part of the 
bladder is termed its body. The lowest part, or neck, of the bladder is attached 
to the pelvic diaphragm and is continuous in the male with the prostate. 
Another fascial support, the lateral ligament, extends backward on each side 
from the base of the bladder to the sacrogenital fold.  
 The triangular area formed between the orifices of the right and left 
ureters and the internal urethral orifice is termed the trigone. Its mucosa is 
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smooth, flat, red to pink, and firmly attached. Muscle fibers between the two 
ureteric orifices raise a fold known as the interureteric ridge. Behind the 
internal urethral orifice, a median fold (the uvula) formed by muscle fibers, the 
middle lobe of the prostate, or by both may develop with increasing age.  
Structure  
 The bladder is composed of the four coats:  
  i. serous 
  ii. muscular 
  iii. submucous 
  iv. mucous coats.     
 The serous coat (tunica serosa) is a partial one, and is derived from the 
peritoneum. It invests the superior surface and the upper parts of the lateral 
surfaces, and is reflected from these on to the abdominal and pelvic walls. 
 The muscular coat (tunica muscularis) consists of three layers of 
unstriped muscular fibers: an external layer, composed of fibers having for the 
most part a longitudinal arrangement; a middle layer, the fibers are arranged, 
more or less, in a circular manner; and an internal layer, in which the fibers 
have a general longitudinal arrangement.  
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 The fibers of the external layer arise from the posterior surface of the 
body of the pubis in both sexes (musculi pubovesicales), and in the male from 
the adjacent part of the prostate and its capsule.  At the sides of the bladder 
the fibers are arranged obliquely and intersect one another. This layer has been 
named the Detrusor urinæ muscle.   
 The fibers of the middle circular layer are very thinly and irregularly 
scattered on the body of the organ, and, although to some extent placed 
transversely to the long axis of the bladder, are for the most part arranged 
obliquely. Toward the lower part of the bladder, around the internal urethral 
orifice, they are disposed in a thick circular layer, forming the Sphincter 
vesicæ, which is continuous with the muscular fibers of the prostate.     
 The internal longitudinal layer is thin, and its fasciculi have a reticular 
arrangement, but with a tendency to assume for the most part a longitudinal 
direction. Two bands of oblique fibers, originating behind the orifices of the 
ureters, converge to the back part of the prostate, and are inserted by means of 
a fibrous process, into the middle lobe of that organ. They are the muscles of 
the ureters, described by Sir C. Bell, who supposed that during the contraction 
of the bladder they serve to retain the oblique direction of the ureters, and so 
prevent the reflux of the urine into them.     
 The submucous coat (tela submucosa) consists of a layer of areolar 
tissue, connecting together the muscular and mucous coats.     
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 The mucous coat (tunica mucosa) is thin, smooth, and of a pale rose 
color. It is continuous above through the ureters with the lining membrane of 
the renal tubules, and below with that of the urethra. The loose texture of the 
submucous layer allows the mucous coat to be thrown into folds or rugæ when 
the bladder is empty. Over the trigonum vesicæ the mucous membrane is 
closely attached to the muscular coat, and is not thrown into folds, but is 
smooth and flat.    
Blood Supply and Lymphatic Drainage.  
 The bladder is supplied mainly by the superior and inferior vesical 
arteries, which arise directly or indirectly from the internal iliac artery. The 
veins drain into the internal iliac vein. The lymphatic vessels go to the 
various iliac nodes.  
Innervation  
 The bladder is supplied by branches of the vesical and prostatic 
plexuses, which are extensions of the inferior hypogastric plexuses.  
The branches include:  
(1) parasympathetic motor fibers to the detrusor (i.e., the muscular coat); (2) 
sensory fibers that are stimulated by stretching, causing a sensation of fullness 
and activating reflexes;   
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(3) sympathetic fibers to blood vessels.  
 Micturition (or urination) is preceded by contraction of the diaphragm 
and abdominal wall. The neck of the bladder descends, the detrusor contracts 
reflexly, and urine is expelled from the bladder.  
Urethra  
 The urethra is a fibromuscular tube that conducts urine from the 
bladder (and semen from the ductus deferens) to the exterior. It begins at the 
neck of the bladder, traverses the pelvic and urogenital diaphragms, and ends 
at the external urethral orifice.  
 The female urethra, about 4 cm in length, is fused with the anterior wall 
of the vagina. It ends between the clitoris and the vagina.  
 The male urethra, about 20 cm in length, comprises three parts: 
prostatic, membranous, and spongy The prostatic part, which is the most 
dilatable, descends through the prostate. Its posterior wall presents a median 
ridge, the urethral crest, the summit of which is termed the colliculus 
seminalis (or the verumontanum). A diverticulum, the prostatic utricle 
(probably corresponding to portions of the uterus and vagina) opens on the 
colliculus, as do the ejaculatory ducts. The prostatic ducts open into a groove, 
the prostatic sinus, on each side of the urethral crest. The membranous part 
descends from the apex of the prostate to the bulb of the penis and is 
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surrounded by the sphincter urethrae. The lowermost part of the membranous 
urethra is liable to rupture or to penetration by a catheter. The spongy part lies 
in the corpus spongiosum and traverses the bulb, body, and glans of the penis. 
It is slightly dilated near its origin (intrabulbar fossa) and termination 
(navicular fossa). The two bulbourethral glands (which are situated bilaterally 
in the sphincter urethrae and behind the membranous urethra) open into the 
proximal portion of the spongy urethra. The external urethral orifice is the 
narrowest portion of the entire urethra.  
Vessels and nerves 
 The artries are derived from inferior vesical and internal pudental 
arteries. 
 The veins drain into vesical and vaginal veins. 
 The nerves are from the pelvic plexus and pudental nerves. 
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RENAL CALCULUS 
 
 Renal Calculus, commonly known as Kidney Stone  is a solid concretion 
or crystal aggregation formed in the kidneys from dietary minerals in the urine. 
 About 80% of those with kidney stones are men. Men most commonly 
experience their first episode between 20-30 years of age, while for women the 
age at first presentation is somewhat later. 
 Normally, urine contains chemicals that prevent the crystals from 
forming. These inhibitors do   not work for everyone and therefore some people 
form stones. If the crystals remain tiny, they travel through the urinary tract 
and pass out of the body via urine without causing any symptoms.  
 The biggest risk factor for kidney stones is not drinking enough fluids.  
Classification 
 Kidney stones are typically classified by their location or chemical 
composition. 
Kidney stones by location 
 Nephrolithiasis (In the kidney) 
 Ureterolithiasis (Ureter) 
 Cystolithiasis (Bladder) 
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Kidney stones by chemical composition 
 Calcium-containing  
 Struvite 
 Uric acid  
 Cystine 
 Other compounds 
 Stones can form when urine contains too much of certain substances. 
These substances can create small crystals that become stones. The stones 
take weeks or months to form. 
Calcium stones 
 Most common. They are more common in men between age 20 - 30. 
 Nearly 80 out of 100 kidney stones (80%) are made of calcium 
compounds, especially calcium oxalate.1 Calcium phosphate and other 
minerals also may be present. 
 Conditions that cause high calcium levels in the body, such as 
hyperparathyroidism, increase the risk of calcium stones.  
 High levels of oxalate also increase the risk for calcium stones. 
 Calcium Phosphate Stones are formed when other underlying health 
conditions are present, especially renal tubular acidosis (RTA). 
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 They usually have a smooth surface, are hard and grow to a large size 
and can damage the kidneys. 
Oxalate stones 
 Oxalate  is present in certain foods such as spinach. It’s also found in 
vitamin C supplements.  
 Diseases of the small intestine increase the risk of these stones. 
Cystine stones 
 Can form in people who have cystinuria. This disorder runs in families 
and affects both men and women. 
Struvite stones 
 About 10 to 15 out of 100 kidney stones (10% to 15%) are struvite 
stones.1 
 They can also be called infection stones if they occur with kidney or 
urinary tract infections (UTIs). These types of kidney stones sometimes are also 
called staghorn calculi if they grow large enough. 
 Struvite stones can be serious, because they are often large stones and 
may occur with an infection.  
 Women are affected more than men because of their higher risk of 
urinary tract infections. 
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 These stones can grow very large and can block the kidney, ureter, or 
bladder. 
Uric acid stones  
 About 5 to 10 out of 100 kidney stones (5% to 10%) are made of uric 
acid, a waste product normally passed out of the body in the urine. common in 
men than in women. 
Occur in people who have   
  Low urine output. 
 A diet high in animal protein, such as red meat. 
 An increase in how much alcohol you drink. 
 Gout. 
 Inflammatory bowel  
Symptoms 
 Symptoms doesnot occur until the stones move down the tubes (ureters) 
through which urine empties into bladder. When this happens, the stones can 
block the flow of urine out of the kidneys. 
 The hallmark of stones that obstruct the ureter or renal pelvis is 
excruciating, intermittent pain that radiates from the flank to the groin or to 
the genital area and inner thigh.[1] This particular type of pain, known as renal 
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colic, is often described as one of the strongest pain sensations known. Pain 
may move to groin area (groin pain) or testicles (testicle pain) 
 Renal colic caused by kidney stones is commonly accompanied by 
urinary urgency, restlessness.  
 Ureteral obstruction causes postrenal azotemia and hydronephrosis 
(distension and dilation of the renal pelvis and calyces), as well as spasm of the 
ureter. This leads to pain, most commonly felt in the flank (the area between 
the ribs and hip), lower abdomen, and groin (a condition called renal colic).  
 Renal colic can be associated with nausea, vomiting, fever, blood in the 
urine, pus in the urine, and painful urination. 
Other symptoms can include: 
 Abnormal urine colour 
 Blood in the urine 
 Chills 
 Fever 
 Nausea 
 Vomiting 
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Mechanical cause 
 Three mechanisms are currently thought to contribute to urinary stone 
formation. They are, 
i)   Precipitation  -  Crystallization from supersaturated   
   solutions 
ii) Absence of inhibits of stone formation normally present in 
 urine 
iii) Presence of macromolecular matrix 
 Precipitation of a substance to form stones depend on many factors 
including solubility, concentration and urine characteristics i.e., pH 7. 
 Normal constituents of urine that inhibit stone formation include citrate, 
pyrophosphate and magnesium. Reduced concentration of these substances 
contribute to stone formation. The disease caused by renal calculi is ‘Gout’. It 
forms the urate calculus. 
Pathogenesis of stones 
 Urinary stones usually arise because of the breakdown of a delicate 
balance. The kidneys must conserve water, but they must also excrete 
materials that have a low solubility. These two opossing  requirements must be 
balanced during adaptation to a particular combination of diet, climate and 
activity. The problem is mitigated to some extent by the fact that urine contains 
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substances that inhibit crystalization of calcium stones and others that bind 
calcium in soluble complexes. But these protective mechanisms are less than 
perfect. When the urine becomes supersaturated with insoluble materials, 
because excretion rates are excessive and / or  because water conservation is 
extreme, crystals from and may grow and aggregate to form a stone. 
Supersaturation 
 In a solution in equilibrium with crystals of calcium oxalate, the product 
of the chemical activities of the calcium oxalate  ions in the solution in termed 
the equilibrium solubility product, because it is the activity product that is 
unique to the equilibrium condition. 
 If the crystals are removed, and if either calcium or oxalate, ions are 
added to the solution, the activity product will increase, but the solution may 
remain clear, no new crystals form. Such a solution is considered to be 
metastably supersaturated. If new calcium oxalate seed crystals are now 
added, they will grow in size, usually the activity product reaches a critical 
value at which a solid phase begins to develop  spontaneously. This value is 
called the upper limit of metastability or the formation product. Stone growth 
in the urinary tract requires a urine that, on the average, is above the 
equilibrium solubility product. Persistance  of a stone requires and average 
activity product at least equal to the solubility product. Execessive 
supersaturation is common in stone formation. 
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 Urine supersaturation can be increased by dehydration or by over 
excretion of calcium, oxalate or phosphate. Supersaturation of the urine with 
cystine or uric acid also occurs, when over excretion of  the urine or low urine 
volume is present. Urine pH can also be an important factor. Phosphate and 
uric acid are weak acids that dissociate readily over the physiological range of 
pH. 
Nucleation 
Homogeneous nucleation  
 In urine that is supersaturated with respect of calcium oxalate, these two 
ions form clusters. The higher the supersaturation, the larger and more 
numerous the clusters become. Most small clusters eventually disperse 
because the internal forces that hold them together are too weak to overcome 
the random tendency of ions to move away. Clusters of over 100 ions can 
remain stable because attractive forces balance surface looses. Once they are 
stable, nuclei can grow at levels of supersaturation below that needed for their 
creatine. The formation product marks the point at which stable nuclei become 
frequent enough to create a permanent solid phase. 
Heterogenous nucleation 
 If a supersaturated urine is  seeded with performed nuclei of a crystal 
that is similar in structure to calcium oxalate, calcium and oxalate ions in 
solution will bind to the crystal’s surface as they would upon a seed crystal of 
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calcium oxalate itself. The organised growth of one crystal on the surface of 
another is called epitaxial  growth, and the seeding of a supersaturated 
solution of foreign nuclei is called heterogenous nucleation.  Sodium, hydrogen, 
urate, uric acid and hydroxyapatite crystals can serve as heterogenous nuclei 
that permit calcium oxalate stones to form even though urine calcium oxalate 
supersaturated never exceeds the metastable limit. 
Inhibitors of crystal growth and aggregation 
 Stable nuclei must grow and aggregate to produce a stone of clinical 
significance. Urine contains potent inhibitors of both of these processes of 
calcium oxalate and calcium phosphate but not for uric acid, cystine are 
struvite. Inorganic pyrophosphate is more than calcium oxalate crystal. Other 
urine components that appear to be glycoproteins inhibit the growth of calcium 
oxalate crystals. Slowing of crystals growth increases the apparent upper limit 
of metastability, because a consequence of the presence of these inhibitors, 
crystal growth in urine is slow compared with growth in simple salt solutions, 
and the upper limit of metastability is higher. Urine citrate may also inhibit 
crystal growth or nucleation.  
Tests 
 The diagnosis of kidney stones is made on the basis of information 
obtained from the history, physical examination, urinalysis, and radiographic 
studies. Ultrasound examination and blood tests may also aid in the diagnosis. 
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 Blood tests to check calcium, phosphorus, uric acid, and electrolyte 
levels 
 Kidney function tests 
 Urinalysis to see crystals and look for red blood cells in urine 
 Examination of the stone to determine the type 
Stones or a blockage can be seen on: 
 Abdominal CT scan 
 Abdominal/kidney MRI 
 Abdominal x-rays 
 Intravenous pyelogram (IVP) 
 Kidney ultrasound 
 Retrograde pyelogram 
Ureteric calculi 
 Form from crystalline aggregates of organic molecules Life time risk of 
developing a ureteric calculus is about 5% Occur most commonly in men aged 
between 30 - 60 years 90% are idiopathic 10% are due to                          
Hyperparathyroidism§ Vitamin D excess§ Primary hyperoxaluria Recurrence 
rate at 10 years is about 50%  
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 Overall, 60% of patients with a ureteric calculus will pass the stone 
spontaneously within 4 weeks and without the need for urological 
intervention.  
 90% of patients with ureteric calculi will have blood in their urine (visible 
or microscopic). 
 70% of ureteric calculi are already in the lower third of the ureter by the 
time of presentation. 
Chemical composition 
 Calcium oxalate (40%) 
 Calcium phosphate (15%) 
 Mixed oxalate / phosphate (20%) 
 Struvite (15%) 
 Uric acid (10%) 
Clinical features 
 Stones usually present with pain due to obstruction of urinary flow. 
 May cause few symptoms or may present with typical ureteric colic 
 Ureteric colic typically is severe colicky loin to groin pain. 
 Pain may radiate into scrotum in men and labia in women. 
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 May also cause frequency, urgency and dysuria 
 Pain may settle with passage of the stone or if stone fails to migrate 
 Abdominal examination is usually unremarkable 
 Microscopic haematuria is often present 
Differential diagnosis 
 The differential diagnosis included renal and non-renal causes
 Renal causes include: 
i) Cystitis and urinary tract infection 
 Although symptoms like frequent micturation, dysuria, microscopic or 
visible haematuria are present in cystitis and urethritis, the typical ureteric 
colic pain (i.e. pain radiating from loin to groin) is present in renal calculus 
(supra pubic pain during and after voiding) is present in cystitis,   desire to 
pass more urine after micturation, due to spasm of the inflammed bladder wall 
is present in cystitis is not usually a symptom of calculi. 
ii)  Pyelonephritis 
 Acute onset of pain in loin radiating to iliac fossae and suprapubic area, 
tenderness in lumbar region, dysuria, vomiting are present in pyelonephritis, 
resembling renal calculus, but fever associated with rigors, urine examination 
showing neutrophils, organisms, tubular epithelial cells are not usually present 
in renal calculus. 
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iii)  Perinephric abscess 
 Marked pain and tenderness are present in this  disease.  But the patient 
will be extremely ill with fever, leucocytosis and positive blood cultures.  
Urinary symptoms are usually absent and the urine contains neither pus cells 
or organisms. 
Non-renal causes include:    
 Appendicitis    
 Ectopic pregnancy    
 Salpingitis    
 Torted ovarian cyst    
 Abdominal aortic aneurysm    
Investigation 
 The following investigations should be considered 
 Midstream urine specimen 
 KUB plus ultrasound 
 Intravenous urogram (IVU) 
Complications
 Complications of ureteric calculi include: 
 Obstruction 
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 Ureteric strictures
 Infection 
 Acute infection in an obstructed kidney is a urological emergency 
 Patient is usually unwell with loin pain, swinging pyrexia and dysuria. 
 Without drainage, rapid renal destruction may occur. 
 Chronic infection with urease-producing organisms (e.g. Proteus) 
precipitates stone formation. 
 Magnesium ammonium phosphate or staghorn calculi result. 
 Staghorn calculi can lead to a deterioration in renal function 
Management 
 Check serum electrolytes and calcium. 
 Urinalysis will normally show microscopic haematuria IVU to confirm 
diagnosis and ureteric obstruction Most 
stones < 5 mm  in diameter pass spontaneously 
 If total obstruction occurs in the presence of infected urine need urgent 
decompression. 
Bladder Stone 
 Vesical calculus or cystolith is a solid concretion or crystal aggregation 
found in the urinary bladder. 
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Causes 
 Bladder stones may occur whenever the kidneys, bladder, or ureters 
become inflamed.  
 The use of urinary catheters may cause a bladder stone.  
 Individuals who are paralyzed or are unable to adequately pass urine 
may require the use catheters placed into the bladder. The use of these tubes 
may lead to an infection, which irritates the bladder, resulting in stone 
formation. Finally, a kidney stone may travel down the ureter into the bladder 
and become a bladder stone.  
  Bladder stones are somewhat more common in men who have prostate 
enlargement. The large prostate presses on the urethra and makes it difficult to 
pass urine. Over time stagnant urine collects in the bladder and minerals like 
calcium start to precipitate.  
 Other individuals who develop bladder stones had spinal cord injury, 
paralysis or some type of nerve damage. When nerves to the back are damaged, 
the bladder cannot empty and stagnant urine results. 
Signs and symptoms 
 Bladder stones are small particles that can form in the bladder. In most 
cases bladder stones develop when the urine becomes very concentrated or 
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when one is dehydrated. This allows for the minerals like calcium or 
magnesium to crystallize and form stones. 
 Bladder stones vary in number size and consistency. In some cases 
bladder stones do not cause any symptoms of signs and are discovered as an 
incidental finding on a plain radiograph. when symptoms do occur these may 
include 
 v fever. 
 v severe lower abdominal and back pain. 
 v difficult urination,/ frequent urination at night. 
 v painful urination and blood in the urine.  
 v The pain may also be associated with nausea, vomiting and chills. 
Diagnosis  
 The diagnosis of bladder stone includes urinalysis, ultrasonography, X 
rays or cystoscopy ) The intravenous pyelogram can also be used to assess the 
presence of kidney stones. 
 CT scans are more sensitive and can identify very small stones not seen 
by other tests. 
Diet for Kidney stones 
Diet for Calcium Stones 
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 It is better to avoid foods and beverages such as coffee, chocolate, and 
fast foods. 
 Vitamin B6 is also reported to reduce urinary calcium. 
 AVOID Oxalate-rich foods include spinach, colocasia, beets, nuts, 
chocolate, black tea, coffee, chocolate milk, dark beers, soy drinks and some 
fruit juices. It is also in butters, wheat bran, whole wheat flour, bran cereals, 
berries, rhubarb, figs, citrus peel,green leafy vegetables, beans, potatoes and 
sweet potatoes, peppers.  
Diet for Uric Acid Stones 
 Food rich in uric acid includes meats, sweet breads. Meats rich in 
purines converts into uricacid. Individuals with uric acid stones or those at 
risk for kidney stones limit themselves of meat ,liver, kidney and brain, meat 
extracts and broths, gravy made from meat.  
1. Drink plenty of fluid   
v Drink more fluid, especially water helps to flush out the kidneys and 
dilute stone-forming substances, making stones less likely to form.   
v Drink at least 2- 3 litres, or 10 cups, of fluid daily.  
v Have a cup of fluid (250mL) each hour during waking hours, and a large 
glass of water before going to bed. 
v Drink a glass of water if you wake up during the night.   
v Spread out your fluid intake during the day.   
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v AVOID strong black tea and orange, juice, as these are high in oxalates. 
v Avoid grape fruit juice,softdrink, Drink 100ml of lemon juice daily (could 
be added to water).   
2.  Limit salt   
 Limit sodium intake to less than 2300mg per day.   
To reduce salt /sodium: 
 Buy fresh foods, or foods without salt - fruit, fresh vegetables, fresh 
meats, chicken, fish, eggs, porridge, rice, pasta  most sodium (75%) comes from         
  processed foods.  
v Limit processed foods high in salt e.g. soup, processed meats, sauces, 
gravy, crisps and snack.  
v  “low salt” or “no added salt” foods are the best choices.  
Surgical Treatments 
 Depending upon the location of the stone, either operative or endoscopic 
approach is chosen.  Endoscopic method is preferred for stones located distal 
to the bladder.  Some of the non-operative techniques devised are extra-
corporeal shock wave lithotripsy(ESWL), precutaneous nephrolithotomy (PCNL) 
and Cystolithotripsy.  These also cause side effects such as haemorrhage, 
hypertension , tubular necrosis and subsequent fibrosis of the kidney.           
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MATERIALS AND METHODS 
 
 A clinical study on “The evaluation of efficacy of the trial medicine 
namely, Aruvagai Chooranam (Internal) in treating Kalladaippu noi”, was 
undertaken at the Post Graduate Department of Pothu Maruthuvam, 
Government Siddha Medical College and Hospital, Palayamkottai. For the 
study, a total of 40 patients of either sex (20 Out-Patients and 20 In-Patients),  
suffering from Kalladaippu noi were selected and administered the said trial 
medicine towards treating the disease. The patients, both in-patients and out-
patients were selected after diagnosing the Kalladaippu noi, through clinical, 
pathological, biochemical and microscopic examination. In addition, Ultra-
Sonogram was also done for all the patients and radiological investigation was 
carried out for the selected cases to confirm the occurrence of Kalladiappu noi, 
diagnosed through the above mentioned routine methods. After discharging the 
in-patients from the IP ward, treatment with the trial medicine was continued 
in the OP Department as follow-up cases. 
Preparation of trial medicines 
 The trial medicine, Aruvagai Chooranam (Internal) is selected based on 
their medicinal values in treating Kalladaippu noi, mentioned in the Siddha 
Literature, Brahmamuni Vaidhya Soothiram - 390, Part - I, Page no. - 120, 
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Edition - II. The ingredients were collected, purified and medicine were 
prepared, stored and given to the patients based on the reference cited above. 
Pharmacological analysis of the trial medicine 
 Pharmacological actions of the trial medicine were studied at KM College 
of Pharmacy Madurai. Experiments were conducted with albino rats (for 
lithotriptic and diuretic activity) by following the standard procedures to 
determine the pharmacological actions like Lithiatic and  diuretic effect of the 
trial medicine. The procedures, results and inferences are given in detail in 
Annexure – I. 
Biochemical analysis of the trial medicine 
 Biochemical analyses of the trial medicine were carried out at the 
Biochemistry Unit of Government Siddha Medical College, Palayamkottai. 
Experiments were conducted by the unit by following the standard procedures 
to know the presence of minerals like Calcium, Sulphate, Chloride, Carbonate, 
Starch, Ferric Iron, Ferrous Iron, Phosphate, Albumin, Tannic Acid, 
Unsaturated Compound, Reducing sugar, Amino Acid and Zinc. The results of 
the biochemical analysis and inferences are given in Annexure – II. 
Criteria for the selection of patients 
 For the present study, patients were selected based on the following 
criteria. 
114 
 
i. Radiological report / Ultra-Sonogram report, indicating the presence of 
Renal Calculi 
ii. Urine analysis report, indicating the presence of crystals, albumin and 
RBC depositions in the urine  
iii. Past history of Renal Calculi 
iv. Clinical history of patients with the following symptoms 
 Renal colicky pain in loin, renal angle and lower abdomen 
 Pain radiating from loin to groin, thigh and external genitalia 
 Abdominal distension   
 Burning micturation 
 Obstruction during micturation 
 Anuria 
 Oliguria 
 Concentric urination 
 Haematuria 
 Pyuria 
 Nausea 
 Vomiting 
 Fever & Chills 
 Sweating 
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Collection and maintenance of Patients’ database 
 A proforma was prepared to collect details about the patients’ personal 
and family history, present symptoms, history of recent and past illness, 
laboratory investigation (including urine and blood analysis), Ultra-Sonogram, 
method adopted for disease treatment and management and  follow-up actions. 
The details collected were recorded in proforma for each individual patient and 
database was maintained for all the patients. 
Investigation of Kalladaippu noi patients 
 The patients were subjected to the following investigations to establish 
the diagnosis. The investigations were carried out regularly before and after the 
treatment. 
i) Urine examination 
 The urine of patients was subjected to microscopic investigations with 
regard to the colour, specific gravity, sugar, albumin, RBCs, cast, pus cells, 
epithelial cells, crystals and other pathological constituents. 
ii) Biochemical examination of blood 
 The blood of patients was tested biochemically to estimate the blood urea 
and creatinine level to know the present functional status of kidney and its 
excretion. 
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iii) Radiography (Plain X-Ray Abdomen KUB) 
 Some of the patients were subjected to radiological examination like X-
Ray KUB. 
iv) Ultra-Sonogram (USG Abdomen KUB) 
 All the patients were subjected to USG Abdomen KUB before and after 
the treatment. 
v) Analysis of kidney stones 
 Knowing the chemical composition of the stone helps the doctor identify 
why the patient is prone to stone formation. The kind of stone a person’s body 
makes determines what dietary changes may be needed. For example, limiting 
oxalate in the diet may help prevent calcium oxalate stones but will do nothing 
to prevent uric acid stones. Some dietary recommendations may apply to more 
than one type of stone. Most notably, drinking enough water helps prevent all 
kinds of kidney stones. In the present study, the kidney stones collected by 
some of the patients during the course of treatment were analysed in a well 
reputed medical laboratory to determine the types of stones. The stone analysis 
reports are given in Annexure – IV. 
Criteria for measuring the positive outcome of the study 
       The positive outcomes of the study included removal of stones with 
urine, removal of disintegrated stones in the form of sand grains with urine, 
absence of crystals, albumin and RBC depositions in urine (evident from urine 
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analysis report), absence of stones (evident from USG report), complete relief 
from / reduction in severity of symptoms like colicky pain, nausea/vomiting, 
haematuria, pyuria and dysuria. The patients were said to be “cured and 
symptom free patients” based on the above mentioned criteria for the positive 
outcomes. 
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OBSERVATION AND 
RESULTS 
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OBSERVATION AND RESULTS 
The results obtained from the present study were recorded in the proforma with respect to the 
following parameters for each patient both out-patients and in-patients. They were analysed statistically to 
arrive at the percentage composition. 
1. Age  
2. Sex  
3. Religion  
4. Occupation 
5. Socio-economic status 
6. Food habits 
7. Personal habits 
8. Aetiological factors 
9. Thinai 
10. Kaalangal 
11. Paruvakaalam 
12. Thegi (Constitution of body) 
13. Mukkutram 
A. Derangement of Vatham 
B. Derangement of Pitham 
C. Derangement of Kabam 
14. Udal Thathukkal 
15. Envagai Thervugal 
16. Neerkuri 
17. Neikuri 
18. Duration of illness 
19. Clinical manifestations 
20. Incidence of various types of calculi 
21. Urine analysis 
22. Ultra sonogram 
23. Stone analysis 
24. Case details and Laboratory investigations  
A. Out-Patients 
B. In-Patients 
25. Grading outcomes of the study 
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Age  
Sl. No. 
Age                    
(in years) 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. 21 – 30 1 5 3 15 
2. 31 – 40 8 40 3 15 
3. 41 – 50 10 50 1 5 
4. 51 – 60 1 5 11 55 
5. Above 60 - - 2 10 
 
In the present study, in out-patients, Kalladaippu noi was found to be most common in the age 
group, 41 – 50 years, and, in in-patients, it was predominant in the age group between, 51 - 60 years.  
 
Sex  
Sl. No. Sex 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Male 13 65 9 45 
2. Female 7 35 11 55 
 
 The above table shows most of the out-patients were males and in-patients were females.  
Religion 
Sl. No. Religion 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Hindu 15 75 20 100 
2. Christian 2 10 - - 
3. Muslim 3 15 - - 
 
It is observed from the above table that majority of the patients were Hindus and the rest were 
Christians and Muslims. 
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Occupation 
Sl. No. 
Age                    
(in years) 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Farmer 1 5 2 10 
2. Coolie 2 10 4 20 
3. Driver 2 10 1 5 
4. Private jobs 7 35 2 10 
5. Govt. employee 3 15 - - 
6. Home maker 5 25 10 50 
7. Gold Smith -  1 5 
 It is understood from the above table that most of the OP were holding private jobs and 
IP were Home makers.  
 
Socio-economic status 
Sl. No. Occupation 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Rich 5 25 - - 
2. Middle class 8 40 14 70 
3. Poor 7 35 6 30 
 
The above mentioned table shows that most of the patients, both OP and IP were hailing from the 
middle class families. 
Food Habits 
Sl. No. Diet 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Vegetarian 2 10 3 15 
2. Mixed diet 18 90 17 85 
 
The above mentioned table shows majority of the patients were taking mixed food, containing both 
vegetarian and non-vegetarian items. 
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Personal Habits 
Sl. 
No. 
Habits 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Alcohol intake 3 15 2 10 
2. Smoking 3 15 4 20 
3. Both alcohol & smoking 3 15 4 20 
4. Tobacco / Betel chewing 2 10 2 10 
5. No bad habits 9 45 8 40 
 
It is observed from the above table that only about 45 % of OP and 40% of IP were found to have 
no bad habits. The rest were having bad habits like drinking alcohol, smoking, tobacco and betel chewing. 
Aetiological factors 
Sl. No. 
Aetiological 
factors 
Out-Patients In-Patients 
Number 
of cases 
% 
Number 
of cases 
% 
1. Family History - - - - 
2. Previous History 3 15 6 30 
3. Recurrent UTI - - - - 
4. Others 17 85 14 70 
 
The result shows that about 15% of OP and 30% of IP had previous history of Kalladaippu noi.  
Others might have got Kalladaippu noi due to drinking contaminated water / hard water, inadequate intake 
of water, altered food habits, poor health awareness, suppressing seminal discharge etc., 
Thinai 
Sl. No. Thinai 
Out-Patients In-Patients 
Number 
of cases 
% 
Number 
of cases 
% 
1. Kurinchi - - - - 
2. Mullai - - - - 
3. Marutham 19 95 20 100 
4. Neithal 1 5 - - 
5. Paalai - - - - 
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In this study, it is learnt from the above table that majority of the out-patients and all the in-patients 
were from Marutha Nilam. 
Mukkutra Kaalam  
Sl. 
No. 
Kaalam (in years) 
Out-Patients In-Patients 
Number 
of cases 
% 
Number 
of cases 
% 
1. Vaatha Kaalam (0 – 33) 2 10 3 15 
2. Pitha Kaalam (34 – 66) 18 90 16 80 
3. Kaba Kaalam (67 – 100) - - 1 5 
 
From the above table, it is understood that most of the out-patients and 
in-patients came under Pitha Kaalam. 
Paruvakaalam 
Sl. No. Kaalam 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Kaar Kaalam 10 50 4 20 
2. Koothir Kaalam 2 10 15 75 
3. Munpani Kaalam - - - - 
4. Pinpani Kaalam - - - - 
5. Ilavenil Kaalam - - - - 
6. Mudhuvenil Kaalam 8 40 1 5 
 
The result reveals that Kalladaippu noi was more commonly seen in karkalam (OP). and in 
Koothikalam (IP)   
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Thegi (Constitution of body) 
Sl. No. Kaalam 
Out-Patients In-Patients 
Number 
of cases 
% 
Number 
of cases 
% 
1. Vatha Thegi 5 25 5 25 
2. Pitha Thegi 13 65 15 75 
3. Kapa Thegi 2 10 - - 
 
The result shows that Pitha thegi patients were affected by Kalladaippu noi more than others. 
Mukkutram 
    A. Derangement of Vatham 
Sl. No. Types 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Praanan - - - - 
2. Abaanan 20 100 20 100 
3. Viyaanan 6 30 7 35 
4. Uthaanan 6 30 4 20 
5. Samaanan 20 100 20 100 
6. Naagan - - - - 
7. Koorman - - - - 
8. Kirugaran - - - - 
9. Devathathan - - - - 
10. Dananjayan - - - - 
 
It is known from the above table that all the patients both OP and IP had disturbances in Abanan 
and Samanan. Only a few patients  had disturbances in Viyanan and Uthanan. 
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B. Derangement of Pitham 
Sl. No. Types 
Out-Patients In-Patients 
Number 
of cases 
% 
Number 
of cases 
% 
1. Anarpitham - - - - 
2. Ranjagam - - - - 
3. Pirasagam - - - - 
4. Sadhagam 20 100 20 100 
5. Alosagam - - - - 
     
The table states that Sadhaga pitham was affected in all the patients. 
 
 
 
C. Derangement of Kapam 
Sl. 
No. 
Types 
Out-Patients In-Patients 
Number 
of cases 
% 
Number 
of cases 
% 
1. Avalampagam - - - - 
2. Kilethagam - - - - 
3. Pothagam - - - - 
4. Tharpagam - - - - 
5. Santhigam 3 15 7 35 
 
The study suggests that only santhigam was affected in 3 of the out 
patients and 7 of the in patients. 
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Udal Thathukkal 
Sl. No. Types 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Saaram 20 100 20 100 
2. Senneer - - 1 5 
3. Oon - - - - 
4. Enbu - - - - 
5. Kozhuppu - - - - 
6. Moolai - - - - 
7. 
Sukkilam / 
Suronitham 
- - - - 
 
It is learnt from the above table  only saram was affected in all the patients. 
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Envagai Theervugal 
Sl. No. Types 
Out-Patients In-Patients 
Number 
of cases 
% 
Number 
of cases 
% 
1. Naa - - 1 5 
2. Niram - - - - 
3. Mozhi - - - - 
4. Vizhi - - 1 5 
5. Malam - - - - 
6. Moothiram 20 100 20 100 
7. Naadi     
 i) Vatha pitham 16 80 15 75 
 ii) Vatha kapam - - - - 
 iii) Pitha vatham 4 20 5 25 
 iv) Pitha kapam - - - - 
 v) Kapa vatham - - - - 
 vi) Kapa pitham - - - - 
8. Sparisam - - - - 
     
The table clearly states that only moothiram was affected in all the patients and  vatha pitha naadi 
was observed in most of the patients. 
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Neerkuri  
Sl. No. Types 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Niram (Colour)     
 Normal 6 30 5 25 
 Yellowish 16 80 14 70 
 Yellowish Red - - 3 15 
 2. Edai (Specific 
Gravity) 
    
 Normal 20 100 20 100 
 Increased - - - - 
 Decreased - - - - 
3. Manam (Smell)     
 Normal 5 25 8 40 
 Tamarind Smell 13 65 10 50 
 Foul Smell 2 10 2 10 
4. Nurai (Frothy)     
 Normal 20 100 20 100 
 Increased     
 Less Frothy     
5. Enjal (Quantity)     
 Increased 1 5 2 10 
 Decreased 14 70 13 65 
 Normal 5 25 5 25 
 
The above table shows that colour of urine was yellowish, smell was like tamarind in most of the 
patients. Nurai and edai were normal in all the patients.  Enjal was decreased in most of the patients. 
Neikuri 
Sl. No. Types Character 
Out-Patients In-Patients 
No. of 
cases 
% No. of cases % 
1. Vatha Neer Lengthens like a snake 6 30 9 45 
2. Pitha Neer Spreads like a ring 12 60 8 40 
3. Kapa Neer Resembles a pearl 2 10 3 15 
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The Neikuri shows that in majority of the patients, pitha neer spread like 
a ring. 
Duration of illness 
Sl. No. Duration 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Less than 1 month 6 30 - - 
2. Between 2 – 6 months 11 55 16 80 
3. Between ½ - 1 year 3 15 3 15 
4. Between 1 – 1½ years - - 1 5 
4. Between 1 – 2 years - - - - 
5. Between 2 – 3 years - - - - 
 
It is learnt from the table that majority of the patients experienced symptoms of Kalladaippu noi 
only in the previous 2-6 months period. 
Clinical manifestations 
Sl. 
No. 
Symptoms 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Renal colicky pain 20 100 20 100 
2. Abdominal distension 4 20 6 30 
3. Burning micturation 17 85 16 80 
4. 
Obstruction during 
micturation 
9 45 7 35 
5. Anuria - - - - 
6. Oliguria 15 75 13 65 
7. Concentric urination 12 60 13 65 
8. Haematuria - - 3 15 
9. Pyuria 20 100 18 90 
10. Nausea & Vomiting 7 35 8 40 
11. Fever & Chills - - - - 
12. Sweating - - 1 5 
 
The study shows that all the patients experienced renal colicky pain and burning micturation. More 
than 50% of the patients experienced oliguria, concentric urination and obstruction during micturation. 
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Incidence of various types of calculi  
Sl. 
No. 
Types  
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Renal Calculi 10 50 17 85 
2. Renal with Ureteric Calculi 4 20 3 15 
3. Vesical Calculi - - - - 
4. Ureteric Calculi 4 20 - - 
5. 
Ureteric Calculi with 
Hydro-ureteronephrosis 
1 5 - - 
6. 
Renal, Ureteric Calculi with 
Hydro-ureteronephrosis 
1 5 - - 
 
 
Ultrasonographic investigations done before the treatment shows that the majority of the patients 
suffered from presence of renal calculi. 
Urine analysis 
Sl. 
No. 
Constituents 
of urine 
Before Treatment After Treatment 
Out-Patients In-Patients Out-Patients In-Patients 
Number 
of 
cases 
% 
Number 
of 
cases 
% 
Number 
of 
cases 
% 
Number 
of 
cases 
% 
1. Albumin 1 5 5 25 - - 1 5 
2. Sugar 1 5 1 5 - - - 5 
 Deposits         
1. Pus cells 16 80 18 90 1 5 2 10 
2. Epithelial cells 4 20 3 15 - - - - 
3. RBCs 4 20 3 15 - - - - 
4. Cast / Crystals - - 2 10 - - - - 
 
The laboratory investigations done before treatment revealed that most of the patients had pus 
cells in their urine and only few had epithelial cells, RBCs and cast / crystals. 
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Ultra-sonography report 
Sl. 
No. 
Location of Calculus 
Before Treatment After Treatment 
Out-Patients In-Patients Out-Patients In-Patients 
No. of 
cases 
% 
No. of 
cases 
% 
No. of 
cases 
% 
No. of 
cases 
% 
1. Renal Calculi 10 50 13 65 2 10 3 15 
2. 
Renal with Ureteric 
Calculi 
4 20 4 20 - - 1 5 
3. Vesical Calculi 0 - 0 0 - - - - 
4. Ureteric Calculi 4 20 3 15 - - - - 
5. 
Ureteric Calculi with 
Hydro-ureteronephrosis 
1 5 0 0 1 5 - - 
6. 
Renal, Ureteric Calculi 
with Hydro-
ureteronephrosis 
1 5 0 0 1 5 - - 
 
Ultrasonographic investigations done after the treatment shows that, majority of the patients had no 
calculus and were free from symptoms of Kalladaippu noi.  
Stone analysis 
Sl. 
No. 
OP / IP No. Name Age / Sex Composition of stone 
1. OP No. 59399 Mr. Velayutham 41 / Male Calcium oxalate and urate 
2. OP No. 64882 Mr. Chelladurai 33 / Male Calcium oxalate and urate 
3. OP. No. 78119 Mr. Ganabathy 50 / Male Calcium oxalate and urate 
 
 Three stones are received from three different patients at the end of the treatment and stones were 
analysed in a renowned laboratory to ascertain the composition of stones. The analysis of the stones 
revealed the presence of calcium oxalate and uric acid. The stone analysis reports of all the three patients 
are enclosed as Annexure V. 
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Grading outcomes of the study 
Sl. No. Response 
Out-Patients In-Patients 
No. of cases % No. of cases % 
1. Good 16 80 13 65 
2. Moderate 3 15 7 35 
3. Poor 1 5 - - 
 
It is understood from the above table that good response was noticed is in 80 % of OP and 65% of 
IP and moderate response in 15% of OP and 35% of IP.  Hence, it can be concluded that the trial medicine, 
Aruvagai Chooranam is very effective in curing Kalladaippu noi. 
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Sl.No O.P.No Name Age/Sex No of days treated Results
1 45406 Mr.kather batcha 32/M 6/18/2012 8/21/2012 64 Good
2 45651 Mrs. Eissakiammal 36/F 6/19/2012 9/13/2012 86 Fair
3 46023 Mrs.Sairabanu 35/F 6/20/2012 9/13/2012 85 Good
4 46256 Mrs. Saroja 50/F 6/21/2012 8/30/2012 70 Good
5 46421 Mr. Soundrarajan 43/M 6/21/2012 7/11/2012 20 Fair
6 46555 Mrs. Padmavathy 37/F 6/29/2012 8/10/2012 42 Good
7 52030 Mr.Kathiravian 44/M 7/10/2012 9/13/2012 65 Good
8 52573 Mr.Sundravel 37/M 7/12/2012 10/31/2012 111 Good
9 52651 Mr. Sunmugasundram 53/M 7/2/2012 8/23/2012 52 Good
10 53229 Mr.Kumaravel 45/M 7/14/2012 10/26/2012 104 Good
11 56437 Mr.Sureshperumal 28/M 7/25/2012 11/2/2012 99 Fair
12 58623 Mr.Ezhilan 43/M 8/2/2012 8/30/2012 28 Poor
13 59399 Mr.velayutham 41/M 8/4/2012 9/11/2012 38 Good
14 60853 Mr.Buhari 40/M 8/9/2012 11/18/2012 101 Good
15 64882 Mr.Chelladurai 39/M 8/23/2012 11/8/2012 77 Good
16 64848 Mr.Jayakani 48/M 8/23/2012 11/2/2012 71 Good
17 64978 Mrs.Kandhimathi 37/F 8/23/2012 11/2/2012 71 Good
18 69425 Mr.Danaraj 42/M 9/6/2012 11/18/2012 73 Good
19 71797 Mrs.Usha 45/F 9/13/2012 12/4/2012 82 Good
20 78119 Mr.Ganapathi 50/M 10/2/2012 11/6/2012 35 Good
CASE DETAILS - OUT - PATIENTS
Course of treatment
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BT- Before Treatment, AT- After Treatment, TC- Total Count, DC- Differential Count, P- Polymorphs, E- Eosinophils, ESR- 
Erythrocyte Sedimentation Rate, Hb- Haemoglobin. 
 
  
Hb (%)
P L E P L E 1/2hr 1 hr 1/2hr 1 hr
1 45406 8,200 8,400 64 30 6 66 32 2 1 3 1 2 13 13.2
2 45651 7,400 7,800 66 28 6 63 32 5 4 10 2 5 11.2 11.4
3 46023 8,000 7,800 59 37 4 64 33 3 4 8 2 4 10.2 10.4
4 46256 7,200 7,600 66 28 6 62 30 8 4 10 3 5 10.8 11
5 46421 8,100 8,300 57 40 3 59 33 8 7 15 4 6 11.5 11.8
6 46555 8,700 8,200 62 30 8 60 38 2 15 25 7 13 11.4 11.6
7 52030 6,000 6,500 63 33 4 62 31 7 2 4 2 3 13 13.2
8 52573 8,400 8,100 70 28 2 60 38 2 6 12 3 6 11.5 11.9
9 52651 7,200 7,800 62 36 2 60 35 5 6 13 2 8 13.5 14
10 53229 8,300 8,400 57 40 3 55 39 6 13 29 7 14 14 14.1
11 56437 8,300 8,000 57 40 3 60 37 3 2 5 1 3 11.5 11.9
12 58623 8,000 8,300 59 37 4 64 30 6 2 5 2 3 13.5 13.6
13 59399 7,900 8,000 62 34 4 55 39 6 5 12 3 6 13 13.4
14 60853 8,000 8,400 66 31 3 60 37 3 10 13 5 7 13 13.6
15 64848 7,100 7,500 66 30 4 60 34 6 8 12 3 4 13.5 13.6
16 64882 7,200 7,600 62 30 8 60 38 2 10 14 5 7 10.1 11
17 64978 9,000 8,800 63 33 4 62 35 3 25 30 10 20 11.2 11.7
18 69425 8,500 8,700 62 36 2 64 30 6 2 5 1 3 13 13.4
19 71797 8,700 8,300 64 34 2 63 32 5 6 14 4 8 13 13.6
20 78119 8,500 8,300 63 33 4 60 32 8 2 5 1 3 13.5 13.7
ATBT
LABORATORY INVESTIGATION - OUT - PATIENTS
AT
BT AT
ESR (mm)TC (Cells/Cumm)
BT AT
DC Cells (%)
O.P.NoSl.No
BT
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1 45406 72 90 18 20 122 125 0.8 0.8 0.5 0.4
2 45651 88 110 19 21 153 150 0.6 0.5 0.9 0.8
3 46023 65 87 15 17 110 113 0.7 0.7 0.4 0.4
4 46256 88 112 18 20 153 145 0.9 0.8 0.6 0.5
5 46421 90 105 21 18 140 143 0.4 0.4 0.7 0.6
6 46555 150 165 26 24 186 192 0.8 0.7 0.9 0.8
7 52030 99 112 21 23 160 166 0.6 0.7 0.8 0.7
8 52573 82 102 22 20 160 168 0.8 0.7 0.4 0.4
9 52651 97 110 19 22 169 172 0.7 0.8 0.6 0.5
10 53229 93 111 20 18 193 198 0.7 0.6 0.7 0.6
11 56437 76.5 97 26.8 22 146 148 0.6 0.5 1.3 0.9
12 58623 72 94 23 21 250 262 0.9 0.7 1.2 1.0
13 59399 77 87 19 21 132 130 0.7 0.6 0.4 0.4
14 60853 101 118 27.2 24 180 172 0.7 0.8 1.1 0.9
15 64848 103 123 24.6 22 260 265 1.0 0.8 1.8 1.5
16 64882 74 96 27 28 165 172 0.8 0.7 0.7 0.7
17 64978 94 102 30 32 170 176 0.6 0.5 0.8 0.6
18 69425 70 84 17 14 151 162 0.6 0.7 0.8 0.5
19 71797 162 170 19 20 175 180 0.6 0.4 0.6 0.6
20 78119 96 118 15 17 209 208 0.9 0.7 0.7 0.4
BT- Before Treatment, AT- After Treatment
LABORATORY INVESTIGATION -( OUT - PATIENTS) - II
Serum Creatinine (mgs %)
AT BT AT
Blood Urea (mgs %) Total Cholesterol (mgs %)
BT AT BT
Sl.No O.P.No
Blood sugar (mgs %)
BT AT AT
Serum Bilirubin (mgs %)
BT
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Albumin
Sugar Pus Cells
Epithelial 
Cells
RBC
Cast / 
Crystals Albumin
Sugar
Pus 
Cells
Epithelial 
Cells
RBC
Cast / 
Crystals
1 45406 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
2 45651 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
3 46023 Nil Nil  2 - 5 FEW PRESENT NAD Nil Nil NAD NAD NAD NAD
4 46256 Nil Nil  2 - 3 NAD PRESENT NAD Nil Nil NAD NAD NAD NAD
5 46421 Nil Nil NAD NAD NAD NAD Nil Nil NAD NAD NAD NAD
6 46555 Trace Trace  2 - 3 NAD PRESENT NAD Nil Trace I- 2 NAD NAD NAD
7 52030 Nil Nil I- 2 I- 2 NAD NAD Nil Nil NAD NAD NAD NAD
8 52573 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
9 52651 Nil Nil NAD NAD NAD NAD Nil Nil NAD NAD NAD NAD
10 53229 Nil Nil  2 - 5 NAD PRESENT NAD Nil Nil NAD NAD NAD NAD
11 56437 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
12 58623 Nil Nil I- 2 FEW NAD NAD Nil Nil NAD NAD NAD NAD
13 59399 Nil Nil NAD NAD NAD NAD Nil Nil NAD NAD NAD NAD
14 60853 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
15 64848 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
16 64882 Nil Nil  2 - 3 I- 2 NAD NAD Nil Nil NAD NAD NAD NAD
17 64978 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
18 69425 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
19 71797 Nil Nil NAD NAD NAD NAD Nil Nil NAD NAD NAD NAD
20 78119 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
Urine Analysis
Before treament After treament
LABORATORY INVESTIGATION -( OUT - PATIENTS) - III
Sl.No O.P.No
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Sl.No I.P.No Name Age/Sex No of days treated Results
1 2200 Mrs.Ramalakshmi 60/F 7/13/2012 8/17/2012 35 Good
2 2451 Mr.Parasivam 47/M 7/27/2012 8/22/2012 26 Fair
3 2606 Mrs.Balammal 60/F 8/8/2012 8/23/2012 15 Good
4 2625 Mrs.Subbammal 67/F 8/9/2012 9/6/2012 28 Good
5 2692 Mrs.Maniammal 43/M 8/14/2012 9/6/2012 23 Good
6 2725 Mrs.Lakshmi 37/F 8/18/2012 9/18/2012 31 Good
7 2801 Mr.Rajaram 53/M 8/28/2012 9/29/2012 32 Good
8 2960 Mr.Mandhiram 44/M 9/6/2012 10/5/2012 29 Good
9 2970 Mrs.Subbulakshmi 37/M 9/7/2012 9/27/2012 20 Good
10 2972 Mrs.Sudha 45/M 9/7/2012 9/27/2012 20 Good
11 3114 Mr.Nathchiar 28/M 9/19/2012 10/27/2012 38 Good
12 3199 Mr.Thankaraj 43/M 9/24/2012 10/8/2012 14 Good
13 3208 Mr.Muthuramalingam 41/M 9/24/2012 10/17/2012 23 Good
14 3505 Mrs.Pappa 40/M 10/10/2012 10/29/2012 19 Good
15 3511 Mrs.Gandhimathi 39/M 10/10/2012 10/29/2012 19 Good
16 3520 Mr.komban 48/M 10/11/2012 11/3/2012 23 Good
17 3523 Mr.Ramakrishnan 37/F 10/11/2012 11/9/2012 29 Good
18 3605 Mr.Arumugam 42/M 10/17/2012 11/6/2012 20 Good
19 3607 Mr.Raj 45/F 10/18/2012 11/6/2012 19 Good
20 3617 Mrs.Manonmani 50/M 10/18/2012 11/9/2012 22 Good
CASE DETAILS - IN - PATIENTS
Course of treatment
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P L E P L E 1/2hr 1 hr 1/2hr 1 hr
1 2200 7,700 7,900 68 30 2 54 37 3 20 30 10 20 12.4 13
2 2451 7,800 7,900 64 33 3 66 31 3 5 12 3 6 12.4 13
3 2606 9,100 9,200 63 33 4 60 37 3 7 16 5 10 10 10.2
4 2625 9,100 9,300 69 28 3 62 34 4 7 15 4 8 10.1 11
5 2692 8,500 8,700 61 26 13 65 32 3 3 6 2 4 12 13.4
6 2725 8,200 8,900 66 31 3 60 36 4 2 5 3 7 12 12.4
7 2801 7,800 7,900 63 33 4 60 38 2 1 3 1 3 12.5 12.7
8 2960 8,100 8,500 59 38 3 66 30 4 10 22 4 12 11.8 12
9 2970 9,000 9,100 63 33 4 59 36 5 2 5 1 3 12 413.6
10 2972 9,100 9,000 61 24 15 59 36 5 7 15 5 10 12 12.6
11 3114 8,900 9,000 61 35 4 60 36 4 20 30 12 22 10.6 11
12 3199 6,900 7,000 57 41 2 60 36 4 2 5 2 4 13.5 13.7
13 3208 9,400 9,600 59 32 9 63 33 4 10 22 7 14 11.2 11.4
14 3505 8,200 8,300 58 38 6 53 34 3 3 7 2 3 11.8 12.8
15 3511 8,400 8,500 56 41 1 56 43 1 10 22 5 10 12 12.4
16 3520 7,000 7,200 62 36 2 59 38 3 18 27 9 18 11.2 11.2
17 3523 9,500 9,600 68 28 4 63 33 4 4 9 3 8 10.8 10.9
18 3605 7,900 8,000 65 32 3 62 34 4 3 7 2 5 12.8 12.8
19 3607 7,500 7,600 62 34 4 60 37 3 10 20 5 10 13 13
20 3617 10,500 10,500 72 25 3 62 36 2 6 13 4 9 10.8 11
LABORATORY INVESTIGATION - IN - PATIENTS
Sl.No I.P.No
TC (Cells/Cumm) DC Cells (%) ESR (mm)
BT AT
BT AT BT AT
BT AT
Hb (%)
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BT- Before Treatment, AT- After Treatment, TC- Total Count, DC- Differential Count, P- Polymorphs, E- Eosinophils, ESR- 
Erythrocyte Sedimentation Rate, Hb- Haemoglobin.
P L E P L E 1/2hr 1 hr 1/2hr 1 hr
1 2200 7,700 7,900 68 30 2 54 37 3 20 30 10 20 12.4 13
2 2451 7,800 7,900 64 33 3 66 31 3 5 12 3 6 12.4 13
3 2606 9,100 9,200 63 33 4 60 37 3 7 16 5 10 10 10.2
4 2625 9,100 9,300 69 28 3 62 34 4 7 15 4 8 10.1 11
5 2692 8,500 8,700 61 26 13 65 32 3 3 6 2 4 12 13.4
6 2725 8,200 8,900 66 31 3 60 36 4 2 5 3 7 12 12.4
7 2801 7,800 7,900 63 33 4 60 38 2 1 3 1 3 12.5 12.7
8 2960 8,100 8,500 59 38 3 66 30 4 10 22 4 12 11.8 12
9 2970 9,000 9,100 63 33 4 59 36 5 2 5 1 3 12 413.6
10 2972 9,100 9,000 61 24 15 59 36 5 7 15 5 10 12 12.6
11 3114 8,900 9,000 61 35 4 60 36 4 20 30 12 22 10.6 11
12 3199 6,900 7,000 57 41 2 60 36 4 2 5 2 4 13.5 13.7
13 3208 9,400 9,600 59 32 9 63 33 4 10 22 7 14 11.2 11.4
14 3505 8,200 8,300 58 38 6 53 34 3 3 7 2 3 11.8 12.8
15 3511 8,400 8,500 56 41 1 56 43 1 10 22 5 10 12 12.4
16 3520 7,000 7,200 62 36 2 59 38 3 18 27 9 18 11.2 11.2
17 3523 9,500 9,600 68 28 4 63 33 4 4 9 3 8 10.8 10.9
18 3605 7,900 8,000 65 32 3 62 34 4 3 7 2 5 12.8 12.8
19 3607 7,500 7,600 62 34 4 60 37 3 10 20 5 10 13 13
20 3617 10,500 10,500 72 25 3 62 36 2 6 13 4 9 10.8 11
LABORATORY INVESTIGATION - IN - PATIENTS
Sl.No I.P.No
TC (Cells/Cumm) DC Cells (%) ESR (mm)
BT AT
BT AT BT AT
BT AT
Hb (%)
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1 2200 82 94 20 24 145 160 0.8 0.8 0.6 0.5
2 2451 81 95 28 30 141 157 0.8 0.8 0.5 0.5
3 2606 57 70 27 26 110 117 0.8 0.8 0.5 0.5
4 2625 130 140 27 24 120 127 0.9 0.9 0.8 0.8
5 2692 68 90 18 17 172 175 0.8 0.8 0.8 0.8
6 2725 93 100 26 22 195 198 0.7 0.7 0.5 0.5
7 2801 98 108 22 21 136 140 0.8 0.8 0.6 0.6
8 2960 100 115 30 25 180 187 0.7 0.7 0.7 0.7
9 2970 90 100 24 26 165 167 0.9 0.9 0.9 0.9
10 2972 85 90 27 26 168 172 0.7 0.7 0.7 0.7
11 3114 75 110 27 27 140 144 0.8 0.8 0.8 0.8
12 3199 90 99 18 19 105 111 0.7 0.7 0.8 0.8
13 3208 94 112 24 27 160 163 0.8 0.8 0.9 0.9
14 3505 66 75 16 20 172 177 0.8 0.8 0.7 0.7
15 3511 70 80 25 30 182 178 0.7 0.7 0.7 0.7
16 3520 95 105 37 36 129 135 0.9 0.9 1.08 1.2
17 3523 96 108 14 16 181 185 0.8 0.8 0.9 0.9
18 3605 74 80 21 20 196 195 0.8 0.8 0.8 0.8
19 3607 68 84 19 18 120 124 0.7 0.7 0.5 0.5
20 3617 86 95 28 29 210 215 0.8 0.8 0.9 0.9
BT- Before Treatment, AT- After Treatment
BT AT
LABORATORY INVESTIGATION -( IN - PATIENTS) - II
Sl.No I.P.No
Blood sugar (mgs %) Blood Urea (mgs %) Total Cholesterol (mgs %) Serum Bilirubin (mgs %) Serum Creatinine (mgs %)
BT AT BT ATBT AT BT AT
119 
 
 
Albumin
Sugar Pus Cells
Epithelial 
Cells
RBC
Cast / 
Crystals Albumin
Sugar
Pus 
Cells
Epithelial 
Cells
RBC
Cast / 
Crystals
1 2200 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
2 2451 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
3 2606 Nil Nil I- 2 FEW NAD NAD Nil Nil NAD NAD NAD NAD
4 2625 Nil Nil I- 2 NAD I- 2 NAD Nil Nil NAD NAD NAD NAD
5 2692 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
6 2725 Trace Trace  2 - 3 NAD NAD NAD Nil Nil NAD NAD NAD NAD
7 2801 Nil Nil I- 2 I- 2 NAD NAD Nil Nil NAD NAD NAD NAD
8 2960 Nil Nil I- 2 NAD NAD Ca. Ox Nil Nil NAD NAD NAD NAD
9 2970 Nil Nil  2 - 3 NAD NAD NAD Nil Nil NAD NAD NAD NAD
10 2972 Nil Nil  2 - 5 NAD  2 - 3 NAD Nil Nil NAD NAD NAD NAD
11 3114 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
12 3199 Nil Nil I- 2 FEW NAD NAD Nil Nil NAD NAD NAD NAD
13 3208 Nil Nil Few NAD NAD NAD Nil Nil NAD NAD NAD NAD
14 3505 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
15 3511 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
16 3520 Nil Nil  2 - 3 I- 2 NAD O. Gr.Ca Nil Nil NAD NAD NAD NAD
17 3523 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
18 3605 Nil Nil I- 2 NAD  2 - 3 NAD Nil Nil NAD NAD NAD NAD
19 3607 Nil Nil Few NAD NAD NAD Nil Nil NAD NAD NAD NAD
20 3617 Nil Nil I- 2 NAD NAD NAD Nil Nil NAD NAD NAD NAD
LABORATORY INVESTIGATION -( IN - PATIENTS) - III
Sl.No I.P.No
Urine Analysis
Before treament After treament
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DISCUSSION 
 
 The present study is “To evaluate the efficacy of trial medicine 
Aruvagaichooranam (Internal)” in the management of kalladaippu. 
(Urolithiasis) 20 out patients and 20 in patients were selected based on clinical 
features and modern investigation parameters. The eight types of siddha 
diagnostic methods (envagai thervu) also carried out. The disease diagnosed 
was confirmed by ultrasonagram. The trial medicine Aruvagai chooranam 
prepared and given to the patients. The reports of urine, blood and general 
details collected from the patients tested before and after treatment were 
analysed to asses the thearapeutic value of  the trail drug Aruvagai chooranam. 
Age 
In this study, among the 20 out-patients, Kalladaippu noi was found to 
be the most common in the age group, 41-50 years. But in case of in-patients, 
it was predominant (55%) in the age group, of 51-60 years.  
Sex  
 It was learnt from the present study that out of 20 OP, occurrence of 
Kalladaippu noi was found to be higher in males (65%) than females (35%). In 
IP, 55% were females and 45% were males. 
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Religion 
It was learnt that majority of the patients were Hindus (75%) of  OP and 
in IP all the patients belongs to  hindus. There were few christians (10%) and 
muslims (15%).  
Occupation 
 The present study revealed that majority of the OP (40%) were holding 
private jobs and IP (50%) were home makers. The rest consisted of coolie (10% 
of OP and 20% of IP), driver (10% of OP and 5% of IP), and government 
employees (15% of OP). Only 5% of OP were farmers and 10% IP were holding 
private jobs. 
Socio-economic status 
Most of the patients (40% of OP and 70% of IP) were hailing from the 
middle class families.  This was followed by patients from the poor families 
(35% of OP and 30% of IP) and rich families (25% OP and 0% IP). 
Food Habits 
Majority of the patients (90% of OP and 85% of IP) were found to take 
mixed food, containing both vegetarian and non-vegetarian items. only 10% of 
OP and 15% of IP were pure vegetarians. 
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Personal Habits 
In this study, 45% of OP and 40% of IP were found to have no bad 
habits. 35% of OP and 15% of IP were alcoholics, 30% of OP and 15% of IP 
were smokers. 25% of OP and 30% of OP were found to drink alcohol and do 
smoking. The rest, 20% of OP and 40% of IP had tobacco / betel chewing 
habits. 
Aetiological factors 
 It was learnt that 15% of OP and 30% of IP had previous history of 
Kalladaippu noi. In the rest of the patients (85% of OP and 70% of IP), 
Kalladaippu noi might be attributed to altered food habits, inadequate water 
intake,  drinking contaminated water / hard water, suppressing seminal 
discharge etc., 
Thinai 
In this study, it was learnt that majority of the out-patients (95%) and all 
the in-patients were from marutha Nilam. Though, siddha literatures have 
mentioned that Marutham is a disease free zone, nowadays all types of 
diseases are found to occur in Marutham due to industrialization, 
urbanization, high human settlement, pollution, altered food habits etc. The 
rest of the patients (5%) were from Neithal Nilam. 
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Mukkutra Kaalam  
From the present study, it was learnt that most of the out-patients (90%) 
and in-patients (80%) fell under Pitha Kaalam (34-66 years). It was followed by 
Vatha Kaalam (10%) for OP and (15%) for IP. It was the least for Kapa Kaalam 
(0%) in for OP and (5%) for IP. 
Paruvakaalam 
 In general, Kalladaippu noi occurs in all the seasons. But in this study, it 
was found to be the commonest during kar kalam (50% of OP) and kuthir 
kalam in IP (75%). During mudhuvenil kalam It was 40% OP and 5% of IP. It 
was 10% OP in Kuthir kalam and 20% of IP in karkalam. 
Thegi (Constitution of body) 
In this study, Pitha thegi patients were found to be the most affected by 
Kalladippu noi (65% of OP and 75% of IP). This was followed by vaddegi 25% of 
OP and 25% of IP. Kapa thegi patients were found to be the least affected (only 
10% of OP). 
Mukkutram 
    A. Derangement of Vatham 
In the present study, it was noted that all the patients under treatment 
had disturbances in Abaanan and Samaanan, which led to oliguria, dysuria, 
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formation of calculi and constipation. Viyaanan was found to be affected in 
30% of OP and 35% of IP which caused severe loin / groin pain and arthritis in 
most of the middle aged and elderly patients. Disturbances in Uthaanan 
resulted in nausea / vomiting in 30% of OP and 20% IP. 
    B. Derangement of Pitham 
Sadhagam was observed to be affected in all OP and IP due to dysuria, 
oliguria and difficulty in their regular work in day to day life.  
C. Derangement of Kapam 
Santhigam was found to be affected in 15% of OP and 35% of IP, causing 
joint pain in elder patients. 
Udal Thathukkal 
Among the seven udal thathukkal, Saaram was observed to be affected in 
all the patients that might have produced symptoms like lethargy and 
depression.  
Envagai Theervugal 
In this study, Moothiram was affected in all the patients. Vatha pitha 
naadi was felt in most of the patients (90% of OP and 75% of IP). This was 
followed by Pitha vatha naadi in 20% of OP and 25% of IP. 
128 
 
Neerkuri  
The colour of the urine was observed to be yellowish in 80% of OP and 
70% IP. Colour was  observed to be normal in 20% of OP and 30% of IP. 
Tamarind smell was felt in 65% of OP and 50% of IP. Foul smell was 
present in 10% of OP and 10% of IP which might be due to the presence of 
plenty of pus cells in their urine. Manam was sensed to be normal in 25% of 
OP and 40% of IP. 
Nurai and edai were found to be normal in all the patients. Enjal was 
observed to be decreased in most of the OP 70% and IP 65% Increased enjal 
was noted in only 5% of OP and 10% of IP. It was found to be normal in 25% of 
OP and 25% of IP. 
Neikuri 
 The study made on Neikuri of the patients showed that in majority of OP 
(60%) and IP (50%),   Pitha neer was observed to spread like a ring. This was 
followed by Vatha neer lengthening like a snake in 30% of OP and 35% of IP. 
The Kapa neer resembled a pearl only in 10% of OP and 15% IP. 
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Duration of illness 
Majority of the patients experienced symptoms of Kalladaippu noi only in 
the past 2-6 months period (55% of OP and 80% of IP) and 30% of OP 
developed symptoms in the last one month period. 
Clinical manifestations 
All the patients were observed to experience renal colicky pain (both OP 
and IP). Next to this, all the patients of OP and 90% IP experienced pyuria, 
followed by oliguria (75% of OP and 65% IP), burning micturation (85% of OP 
and 80% of IP), concentric urination (60% of OP and 65% of IP), obstruction 
during micturation (45% of OP and 35% of IP). Only few patients experienced 
symptoms like haematuria, nausea, vomiting and sweating. 
Incidence of various types of calculi  
Ultrasonograph of the patients before the treatment revealed that the 
majority of the patients (50% of OP and 65% of IP) suffered from presence of 
renal calculi. This was followed by ureteric calculi (20% of OP and 15% IP), 
renal with ureteric calculi (20% of OP and 20% of IP), ureteric calculi with 
hydro-ureteronephrosis (5% of OP) renal and ureteric calculi with hydro-
ureteronephrosis (5% of OP and 0% IP). No vesical calculi was observed to be 
found in OP, and IP. 
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Urine analysis 
The laboratory investigations done before treatment revealed that 80% of 
OP and 90% of IP had pus cells in their urine. A few had epithelial cells (20% of 
OP and 15% of IP). RBCs were found in the urine 20% of OP 15% of IP and cast 
/ crystals in 5% of IP only. After the treatment, most of the patients were found 
to have no pus cells and epithelial cells in their urine. 
Ultra-sonography report 
Ultra-sonographic investigations conducted after the treatment revealed 
that, majority of the patients (80% of OP and 80% IP) had no calculus and were 
free from symptoms of Kalladaippu noi.  
Stone analysis 
 Three stones were received from 3 different patients at the end of the 
treatment. Three stones were analysed in a wellreputed laboratory to know the 
composition of stones. The analysis of the stones indicated the presence of 
calcium oxalate and urate. The stone analysis reports of all the three patients 
are enclosed as Annexure V. 
Precipitating factors 
 In the present study, the personal history of patients and laboratory 
investigations revealed that the occurrence of Kalladaippu noi might be 
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attributed to altered food habits , drinking contaminated water / hard water, 
inadequate water intake, suppressing seminnal discharge, and poor health 
awareness. 
Treatment 
 The trail medicine selected for the clinical study was Aruvagai 
chooranam 2 gm BD morning & Evening with hot water afer food. 
 All the patients were advised to follow pathiyam and drink plenty of 
purified water. In addition, they were advised to avoid tomato, cauliflower, 
cabbage, dairy products etc. 
 The present study proved the therapeutic values of the trial medicine 
which is evident from the absence of calculi and symptoms associated with 
kalladaippu noi in majority of the patients. Good response was noticed in 80% 
of OP and 80% of IP and moderate response in 15% of OP and  20 IP. Poor 
response was observed in only one out patient (5%) only. This is because the 
calcules could not cross the vesico ureteric junction due to the anatomical 
narrowing of the consistriction of the ureter. The good and moderate response 
of trial medicine in treating Kalladaippu noi are attributed to the lithotriptic 
action diuretic effect, anti-spasmodic effect, antibacterial, cooling, and 
demulcent effect of the trial medicine.  
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SUMMARY 
 
 A clinical study on Kalladaippu noi with the following trial medicine was 
undertaken for my dissertation work at the Post Graduate Department of Pothu 
Maruthuvam, Government Siddha Medical College and Hospital, 
Palayamkottai. 
i. Aruvaghai Chrooranam 2gm BD morning & Evening  with hot water 
after food (internal). 
The study was undertaken 
1. To find out the efficacy of the trial medicine in dissolving or breaking 
the calculi into fragments. 
2. To know the efficiency of the medicine in spontaneous expulsion of 
the calculi. 
3. To know about the recurrence (or) any adverse effects in the patients 
during the course of treatment with the trial medicine. 
 The patients showed good prognosis within a short period. Ureteric colic 
and burning micturation  reduced within one week of treatment. It was 
observed that all other signs and symptoms relieved at  the end  of course of 
the treatment with the trial medicine and strict diet restriction (pathiyam). 
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From the clinical examination and enquiring the patients, it was noted that 
stones got broken and fragmented and passed out in the form of sand grains 
with urine. It was evident from the laboratory and ultra-sonographic 
investigations that the trial medicines helped in the spontaneous expulsion of 
calculi in some of the patients. Good response was noticed is in 80% of OP and 
80% of IP and moderate response in 15% of OP and 20% of IP. Poor response 
was in only one in-patient (only 5% of OP).  
 The patients were advised to take the trial medicine, Aruvagai 
Chooranam after food. As the ingredients incorporated in the trial medicine 
have cooling, lithotriptic action, demulcent diuretic and antispasmodic effect, 
they should have compensated the deranged pitham in Kalladaippu and 
initiated diuretic action to expel the stone.  The patients were advised to 
restrict diet to avoid recurrence. 
 The pharmacological study revealed that the trial medicine had 
lithotriptic, diuretic and anti-spasmodic effects. The literatures have not 
reported any toxic effects of the ingredients incorporated in the trial medicine. 
Accordingly, the patients under treatment also had not experienced adverse 
effects during the course of treatment with the trial medicine. From this study, 
it has been proved that the trial medicine, Aruvagai Chooranam (Internal) are 
highly effective and economicaly viable in curing Kalladaippu noi. 
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CONCLUSION 
 
 The following conclusions have been drawn from the clinical study on 
“The evaluation of efficacies of the trial medicine namely, Aruvagai Chooranam 
(internal) in treating Kalladaippu noi”, undertaken at the PG Department of 
Pothu Maruthuvam, Government Siddha Medical College and Hospital, 
Palayamkottai as my dissertation work.  
1.  The pharmacological study on trial medicine revealed the lithotriptic, 
diuretic and anti-spasmodic effect of the trial medicine - Annexure I.  
2. The biochemical analysis of trial medicine revealed the presence of 
various minerals like Calcium, Chloride,  and Ferrous Iron  - Annexure 
II. 
3. The microbiological analysis reveald the antibacterial activity of trial 
medicine. Annexure III  
4. The ingredients incorporated in the trial medicine helped to cure 
Kalladaippu noi by compensating the increased pitham which is 
attributed to the diuretic, lithotriptic action, anti-spasmodic effect, 
cooling and demulcent effect as mentioned in the various siddha 
literatures - Annexure IV. 
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4. The analysis of the stones of some the patients revealed the presence of 
calcium oxalate and urate - Annexure V. 
5. Clinically, the trial medicine are free from side effects as no patient 
experienced side effects during the course of treatment. 
6. The result showed good response in 85% of OP and 80% of IP and fair 
response in 15% of OP and 20% of IP. Poor response was observed in only 
one patient (5% of OP only) due to the antomical narrowing of the vesico 
ureteric junction presence of large sized calculus.    
 The trial medicine were found to have lithotriptic, diuretic anti-
spasmodic effect, antibacterial activity and have properties to compensate the 
increased pitham, which is one of the important causes for Kalladaippu. From 
this study, it has been proved that the trial medicine, Aruvagai Chooranam 
are highly effective and economicaly viable in curing Kalladaippu noi. 
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PREPARATION OF TRIAL MEDICINE 
ARUVAGAI CHOORANAM (Internal) 
 The “ Aruvagai Chooranam” was prepared in accordance with the 
following reference. 
NLX úSônLhám AñYûLf ÑWQm 
 §YWúY NLXúSônLhám ùNôpXd úLð 
  £WLjúRô P¾UçWm SôLl ×îm 
 RôWUe Lìg£WLm YXeLl ×îg 
  NRálûT YûLYûLdál TXkRô ù]ôuñ 
 ÏWúY NoLôñm BñTXg ùNôuú]ôm 
  ùLôjRUpÄ TXUôñ NU]ôn Ïh¼ 
 úNìúU YûLùVu] TuÉ WiPôfã 
  £ÉLtLiå TXmTÉ ùWiPôúU. 
 TuÉùWiåm ùYpùYú\ C¼jç Ju\ôn 
  TôeLô] LôºùVu\ úUìÅúX AûPjç 
 EuÉúV ùYñL¼jÕs Ak¾Nk¾ ùLôsð 
  Jì úSWm ùYu²oùLôs ðiûU VôLd 
 áu]ôç N¬W¾Pm áûXùVÃî áuUm 
  ùLô¼Rôu ùSgãYÄ AúWôºLêm úTôám 
 EuÉúV ºWºpúSô ùYpXôk §ìm 
  KåúU ÀjRùUôå ÀWhPp ¨ÚWp 
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 Li½p¨o TônfNXñm ÀWLôN Uôám 
  LXeLôç éj¾Vç UkRk §ìm 
 §ìúU ¿j¾ûWëm ãLêi Pôám 
  §WôR éïd¸ìÁ úNôûL úTôám 
 YôìúU CåléYÄ LpXûPlé YÄlé 
  YônúLôQp Yôná[\p YôR ÀjRm 
 §ìúU ùNÅúSôëg ùNÅå FûU 
  úNjçUêm ÀpÄùVôå YgNû]ëk §ìm 
 NôÃåúU ùRôiûPléi LiP UôûX 
  N¬Wj¾p ¨oLhå Nôokç úTôúU. 
ÀWmUêÉ ûYj¾V Ñj¾Wm - 390 , TôLm - 1, TdLm - 120 
i) Ingredients 
 The following raw drugs required for the preparation of trial medicine, 
Aruvagai Chooranam were purchased.  
Sl. No. Name of the drugs Chemical / Botanical Name Parts used Quantity (gm) 
1. Seeragam  Cuminum Cyminum Purified Seeds 105 
2. Athimathuram  Glycyrrhiza glabra Purified Root 105  
3. Sirunaga Poo   meusua  ferra Purified Dried flowers 105  
4. Karunseeragam  nigella sativa Purified Seeds 105  
5. Elavanga Poo  syzygium aromaticum  Purified Dried flowers 105 
6. Sathakuppai Anethum graveolens Purified Dried Fruits 105 
7. Kotthamalli coriandrum sativum Purified Seeds 630 
8. Whitesugarcandy Saccharum Officinarum Juice 1260  
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ii) Purification of Drugs 
Athimathuram : 
Remove the bark, take the central portion of the root , cut into small 
pieces  and dried in sunlight. 
 Drugs other than Athimathuramver are cleaned fried slightly and taken. 
PROCESS OF PREPARATION 
 All the purified and processed drugs are finely powdered seperately and 
mixed with white sugar candy. 
Reference :Gunapadam Thathu jeeva vaguppu 
Dosage: 2 gm  with water  BD morning and evening  
Duration:   
 30 days 
Drug storage 
 The trial drug Aruvagai chooranam is stored in clean and airtight narrow 
mouthed Bottles. 
Dispensing 
 For out patients, the chooranam is given in 2 gm packets and totally four 
packets are given for two days. 
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AñYûLf ÑWQm úNìm UìkçLs 
£WLm 
 Yôk¾ VìºáuUm YônúSônÀ −LÁûWl 
 úTt¾ìUX LpXûPlÀ XôgN]êm - úNokRLmUp 
 BN]á PôÃùVòm AkRd ¸WL½ëm 
 TôN]á PôÃëiQl úTôm. 
áQTôPm 1m TôLm, ØÄûL Yálé, Td.369 
A¾UçWm 
 A¾UçWm úT¬kçd Lô]áQe úL°o  
 ùLô¾UìYôl ÀjRe áñáúU-ç¾UìYôn 
 ¨Wçî êiPôm ¿ûXVôR RôTmúTôm 
 TôWÈVf ùNôuú]ôm TLokç. 
áQTôPm 1m TôLm, ØÄûL Yálé, Td.10 
ºñSôLl×  
 ºñSôLl ×Å]ç ùNnûLRû]f ùNôpúYôm 
 áÈVôám úULjûRd ùLôpím-ùSÈÅhåj 
 §Rônf ùNpYôëûYëk §odáÁì UtúTôdám 
 úLôRôn! CûRVÈkç ùLôs. 
áQTôPm 1m TôLm, ØÄûL Yálé, Td.357 
Lìg£WLm 
 Lìg£ WLjRô] LWlTù]ôå éiæm 
 YìgºWônl ©SNê Uôtñm - Aìk¾]ôp 
 LônfNp RûXYÄëe LiYÄëm úTôêX¸p 
 YônfN UìkùR]úY ûY. 
áQTôPm 1m TôLm, ØÄûL Yálé, Td.372 
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CXYeLl× 
 ãd¸XSh PeLoQ ÑoÅVeL XôgN]kRôh 
 ºdLpÅPôf NoYô ºVlÀ½ë-Ud¸dáh 
 PeLl ×úYôå RÃTPìk úRôuÈÄp 
 YeLl× úYôåûWjç Yô. 
áQTôPm 1m TôLm, ØÄûL Yálé, Td.86 
NRálûT 
 YôRùUôå Ñ¾Lô YôRm ºWãúSôn 
 úUôçùNÅ úSônLTúSôn ØåãWm-Kç¸u\ 
 ØXd Lålé ê¾o©SNm úTôám 
 OôXf NRálûT Sôå. 
áQTôPm 1m TôLm, ØÄûL Yálé, Td.340 
 
ùLôjRUpÄ 
 ùLôjçUpÄ ùYlTm áÇoLônfNp ÀjRUkRg 
 Noj¾ÅdLp RôLùUôå RôçShPm-Lj¾ùVïm 
 YôR ÅLôoUPo YuLojR ÀÅWQm 
 ×RXj¾p XôRLtñm úTôtñ. 
áQTôPm 1m TôLm, ØÄûL Yálé, Td.315 
£]ôLtLiå 
 DÈu R¼lé ÁìUímTp Yôk¾Lðg 
 £ñLT Øh¼]êg úNWôúR - úRÈVSt 
 ùNôtLi ¼[eáÂpLs ÑZ UPY]úU! 
 LtLi ùP]îûWdáe Lôp. 
áQTôPm 1m TôLm, ØÄûL Yálé, Td.189 
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STANDARD OPERATING PROCEDURES FOR THE PREPARATION OF 
ARUVAGAI CHOORANAM 
SOURCE OF TRIAL MEDICINE 
 The required raw drugs for preparations  of  ARUVAGAI CHOORANAM 
are purchased from well reputed country shop and raw  drugs are identified 
are authenticated by Pharamacognsy expert of Govt Siddha Medical College, 
Palayamkottai.  Then drugs are purified  and medicine is prepared in 
P.G.Gunapadam practical hall  of Govt Siddha medical college Palayamkottai. 
TREATMENT: 
INTERNAL MEDICINE 
 ARUVAGAI CHOORANAM 
A) INCREDIENTS 
1) SEERAGAM-105gm 
 Seeds of cuminum cyminum 
2) ATHIMADURAM 
 Roots of glycyrrhizae glabra 
3) SIRUNAGAPOO 
 Dried flowers of meusua  ferra 
151 
 
4) KARUNSEERAGAM 
 Seeds of nigella sativa 
5) ELAVANGAPOO 
 Dried flowers of syzygium aromaticum  
6) SATHAKUPPAI 
 Dried fruits Anethum graveolens 
7)  KOTTHAMALLI 
 Dried  fruits of coriandrum sativum 
8) CHEENA KARKANDU 
 White sugar candy 
Athimathuram 
Remove the bark, take the central portion of the root , cut into small 
pieces  and dried in sunlight. 
 Drugs other than Athimathuramver are cleaned fried slightly and taken. 
PROCESS OF PREPARATION 
 All the purified and processed drugs are finely powdered seperately and 
mixed with white sugar candy. 
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Reference :Gunapadam Thathu jeeva vaguppu 
Dosage: 2 gm  with water  BD morning and evening  
Duration:   
 30 days 
Drug storage 
 The trial drug Aruvagai chooranam is stored in clean and airtight narrow 
mouthed Bottles. 
Dispensing 
 For out patients, the chooranam is given in 2 gm packets and totally four 
packets are given for two days. 
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EVALUATION OF ANTILITHIATIC ACTIVITY OF ARUVAGAI CHOORANAM IN 
EXPERMENTAL ANIMALS: AN IN VIVO STUDY. 
Introduction 
Renal lithiasis defined as the consequence of an alteration of the normal crystallization 
condictions of urine in the urinary tract.
1 
Urine composition factors are important in crystal 
formation as urine is a metastable liquid containing several coexisting substance that can 
crystallize to generate renal calculi. These substances are present at super saturation levels. The 
ease of crystallization depends on the degree of super saturation, the presence of performed 
particles (heterogeneous nucleants that act as promoter substances) and the level of 
crystallization inhibitors (inhibits crystal nucleation and growth)
2
.    Some of the substances 
found in the urine are able to crystallize and in a concentrated form these chemicals can 
precipitate into a solid deposit attach to the kidney walls. These crystals can grow through a 
process of accretion to form a kidney stone.
3
 Nephrolithiasis has afflicted mankind since 
antiquity and can persist, with serious medical consequences, throughout patient’s life time, with 
a recurrence rate of 70-80% in males and 47-60%in females. The present day medical 
management of nephrolithiasis is either costly or not without side effects. Hence the search for 
antilithiatic drugs from natural sources has assumed greater importance. Many Indian plants have 
been quoted to be useful as anti lithiatic agents . They are effective with fewer side effects and 
are also inexpensive. In the present study, an effort has been made to establish the scientific 
validity for the anti urolithiatic property  of  Aruvagai chooranam using ethylene glycol induced 
hyperoxaluria model in rats.  
 
155 
 
 
Materials and methods: 
Preparation of the chooranam 
Here add method of preparation of chooranam 
Pharmacological screening of antilithiatic activity 
Animals 
Male albino wister rats (180-200gm) were obtained from chellamuthu Trust ( Madurai, India). 
They were housed in well ventilated cages (3 to4 per cage) maintained at 25±2
0
C under 12hour 
dark/light cycle. They were fed with standard pellet diet and had free accesses to water. The 
animals were maintained in these conditions for 1 week before the experimental session. Our 
institutional animal ethical committee (IACE) approved this study. 
Ethylene glycol induced Antilithiatic activity 
The acclimatized animals were divided into 2 main groups one is prophylactic group and the 
other curative group each containing 4 sub groups of each 6 animals. 
Prophylactic group 
Group 1 : Served as normal control and receive normal diet. 
Group 2 : Served as lithiatic control and received 1% ethylene glycol in drinking water for 28 
days and normal diet. 
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Group3 : Received 1% ethylene glycol in drinking water along with aruvagai chooranam 
200mg/kg for 28days. 
Group 4 : Received 1% ethylene glycol in drinking water along with cystone herbal tablet 
100mg/kg for 28 days. 
Curative group 
Group 1 : Served as curative control and receive normal diet. 
Group 2 : Served as lithiatic control and received 1% ethylene glycol in drinking water for 28 
days and normal diet. 
Group3 : Received 1% ethylene glycol in drinking water for 28days then treated  with aruvagai 
chooranam 200mg/kg for next 15 days. 
Group 4 : Received 1% ethylene glycol in drinking water for 28 days then treated  with cystone 
100mg/kg for next 15 days. 
Assessment of antilithiatic activity 
Urine  sampling 
For prophylactic treatment on the 24
th
 hour urine samples were collected from rats, housed in 
metabolic cages, on the 14
th
 day and 28
th
 day urine volume noted. Urinary and serum parameters 
like calcium, Phosphate, Magnesium, Oxalate, Protein, Uric acid and creatinine concentration 
were estimated using auto analyzer. 
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For curative treatment on the 24
th
 hour urine samples were collected from rats, housed in 
metabolic cages, on the 43rd  day urine volume noted. Urinary and serum parameters like 
calcium, Phosphate, Magnesium, Oxalate, Protein, Uric acid and creatinine concentration were 
estimated using auto analyzer. 
Blood sampling 
All rats were anaesthetized with diethyl ether; blood was collected from retro orbital puncture of 
the animal. Then centrifuged for 10 minutes at 3000 r.p.m. to separate the serum. The serum of 
each animal of all the groups was estimated for calcium, magnesium, oxalate, Phosphate 
creatinine and uric using their respective kits in the laboratory. 
Histopathological studies 
The kidney were carefully removed , washed in ice cold 0.15M Kcl. The kidney were fixed in 
formaldehyde (10%) for H.E (Hematoxylin Eosin) stain. The crystal deposit was visually 
examined under light microscope. 
RESULT 
In the present study chronic administration of 1% ethylene glycol aqueous solution to 
male wistar rats resulted in hyperoxaluria. Urinary concentration of various ions was investigated 
for prophylactic treatment at the 14
th
 day and 28
th
 day of the study varied drastically, following 
ethylene glycol treatment. The values of urinary protein, calcium and uric acid at 14
th
 day were 
62.78±3.64mg/dl, 5.58±0.50mg/dl, 3.11±0.63mg/dl respectively. On the 28
th
 day the values of 
urinary protein, calcium and uric acid was 69.83±3.84mg/dl, 6.10±0.67 and 3.28±0.55mg/dl 
respectively in G1 rats. These values increased significantly in the animals treated with ethylene 
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glycol in G2. The values of urinary protein, calcium and uric acid at 14
th
 day was 
148.16±8.24mg/dl 19.25±1.96mg/dl and 12.41±1.50 respectively and the 28
th
 day values are 
156.33±7.25mg/dl, 19.03±1.55mg/dl, 13.55±1.29mg/dl (p<0.001) respectively. The animals 
when treated with aruvagai chooranam 200mg/kg and cystone 100mg/kg body weight 
respectively in G3 and G4 respectively, the values are restored to near normal values as shown in 
table 1 and 2. 
The values of urinary creatinine, oxalate, phosphate increased significantly in the animals treated 
with ethylene glycol in G 2 when compared with the normal control animals in G1 in the 
prophylactic study. The values at 14
th
 day was 1.52±0.12mg/dl, 32.40±3.36mg/dl and 
72.58±4.11 respectively and the 28
th
 day values are 1.75±0.20mg/dl, 47.15±4.45mg/dl, 
75.58±4.11mg/dl (p<0.001) respectively. The animals when treated with aruvagai chooranam 
200mg/kg and cystone 100mg/kg body weight respectively in G3 and G4 respectively, the values 
are restored to near normal values as shown in table 1 and 2. 
The values of urinary magnesium in the prophylactic study at 14
th
 day were 4.05±0.43mg/dl, on 
the 28
th
 day the value was 4.38±0.55mg/dl, in G1 rats. These values decreased significantly in 
the animals treated with ethylene glycol in G 2. The value urinary magnesium at 14
th
 day was 
0.93±0.16mg/dl and the 28
th
 day value was 1.30±0.23mg/dl, (p<0.001). The animals when 
treated with aruvagai chooranam 200mg/kg and cystone 100mg/kg body weight respectively in 
G3 and G4 respectively, the values are restored to near normal values as shown in table 1 and 2. 
In the prophylactic group the serum uric acid, creatinine, phosphate, calcium, and oxalate were 
increased in the ethylene glycol alone treated rats and the values were regained to the near 
normal values in aruvagai chooranam 200mg/kg and cystone 100mg/kg treated rats as shown in 
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the table 3. The serum magnesium level is decreased in the ethylene glycol alone treated rats and 
the values were regained to the near normal values in aruvagai chooranam 200mg/kg and cystone 
100mg/kg treated rats as shown in the table 3.  
In the curative group the urine and serum parameters like uric acid, creatinine, phosphate, 
calcium, and oxalate were increased in the ethylene glycol alone treated rats and the values were 
regained to the near normal values in aruvagai chooranam 200mg/kg and cystone 100mg/kg 
treated rats as shown in the table 4 and 5. The urine and  serum magnesium levels were 
decreased in the ethylene glycol alone treated rats and the values were regained to the near 
normal values in aruvagai chooranam 200mg/kg and cystone 100mg/kg treated rats as shown in 
the table 4 and 5. 
DISCUSSION 
In the present study, male rats were selected to induce urolithiasis because the urinary 
system of male rats resembles that of humans and also earlier studies have shown that the 
amount of stone deposition in female rats was significantly less. Urinary super saturation with 
respect to stone-forming constituents is generally considered to be one of the causative factors in 
calculogenesis. Evidence in previous studies indicated that in response to 14 day period of 
ethylene glycol (0.75%, v/v) administration, young male albino rats form renal calculi composed 
mainly of calcium oxalate (4). 
The biochemical mechanisms for this process are related to an increase in the urinary 
concentration of oxalate. Stone formation in ethylene glycol fed animals is caused by 
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hyperoxaluria, which causes increased renal retention and excretion of oxalate. Similar results 
have been obtained when rats were treated with ethylene glycol and ammonium oxalate.(5). 
In the present study, oxalate and calcium excretion are progressively increased in calculi-
induced animals (Group II). Since it is accepted that hyperoxaluria is a far more significant risk 
factor in the pathogenesis of renal stones than hypercalciuria (6), the changes in urinary oxalate 
levels are relatively much more important than those of calcium (7). Increased urinary calcium is 
a factor favoring the nucleation and precipitation of calcium oxalate or apatite (calcium 
phosphate) from urine and subsequent crystal growth (8). However, aruvagai chooranam 
200mg/kg and cystone 100mg/kg lower the levels of oxalate as well as calcium excretion. 
An increase in urinary phosphate is observed in calculi induced rats (Group II). Increased 
urinary phosphate excretion along with oxalate stress seems to provide an environment 
appropriate for stone formation by forming calcium phosphate crystals, which epitaxially induces 
calcium oxalate deposition (9). Treatment of aruvagai chooranam 200mg/kg and cystone 
100mg/kg  restores phosphate level, thus reducing the risk of stone formation. In urolithiasis, the 
glomerular filtration rate (GFR) decreases due to the obstruction to the outflow of urine by 
stones in urinary system. Due to this, the waste products, particularly nitrogenous substances 
such as urea, creatinine and uric acid get accumulated in blood (10). Also, increased lipid 
peroxidation and decreased levels of antioxidant potential have been reported in the kidneys of 
rats supplemented with a calculi-producing diet (11,12). In this context, oxalate has been 
reported to induce lipid peroxidation and to cause renal tissue damage by reacting with 
polyunsaturated fatty acids in cell membrane (13). In calculi-induced rats (Group II), marked 
renal damage was seen as indicated by the elevated serum levels of creatinine and uric acid. 
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However, the curative and prophylactic treatment with aruvagai chooranam 200mg/kg and 
cystone 100mg/kg causes diuresis and hastens the process of dissolving the preformed stones and 
prevention of new stone formation in urinary system. 
 
CONCLUSION: 
In conclusion, the presented data indicate that administration of the aruvagai chooranam 
200mg/kg and cystone 100mg/kg to rats with ethylene glycol induced lithiasis, reduced and 
prevented the growth of urinary stones, supporting folk information regarding anti urolithiatic 
activity of the aruvagai chooranam. The mechanism underlying this effect is still unknown, but is 
apparently related to increased diuresis and lowering of urinary concentrations of stone forming 
constituents. These effects could conclude the anti urolithiatic property of aruvagai chooranam. 
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TABLE 1: EFFECT OF ARUVAGAI CHOORANAM  AND CYSTONE ON URINARY 
BIOCHEMICAL PARAMETERS ON THE DAY 14 
•  
•  
• Values are expressed as Mean± SEM 
• Values were find out by using ONE WAY ANOVA Followed by  Newman keul’s 
multiple range test 
• **(a)values were significantly different from normal control G1 at P< 0.01 
• **(b) values were significantly different from Lithiatic control G2 at P<0.01 
 
  
GP 
Protein 
(mg/dl) 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl) 
Uric 
acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
G1 
62.78± 
3.64 
4.05± 
0.43 
5.58± 
0.50 
3.11± 
0.63 
0.75± 
0.06 
14.75± 
1.71 
30.81± 
2.15 
G2 
148.16 ± 
8.24
**(a)
 
0.93 ± 
0.16
**(a)
 
19.25 ± 
1.96
**(a)
 
12.41 ± 
1.50
**(a)
 
1.52 ± 
0.12
**(a)
 
32.40 ± 
3.36
**(a)
 
72.58 ± 
4.11
**(a)
 
G3 
74.35± 
5.23
**(b)
 
3.10± 
0.65
**(b)
 
6.57± 
0.45
**(b)
 
4.10± 
0.65
**(b)
 
0.87± 
0.07
**(b)
 
17.56± 
1.47
**(b)
 
33.34± 
2.36
**(b)
 
G4 
80.22± 
6.30
**(b)
 
2.80 ± 
0.55
**(b)
 
7.78 ± 
0.62
**(b)
 
5.15 ± 
0.91
**(b)
 
0.92 ± 
0.08
**(b)
 
20.10 ± 
1.85
**(b)
 
36.26 ± 
2.50
**(b)
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TABLE 2:EFFECT OF ARUVAGAI CHOORANAM  AND CYSTONE ON URINARY 
PARAMETERS IN PROPHYLACTIC TREATMENT OF ANIMALS 
GROUP 
Protein 
(mg/dl) 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl) 
Uric acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
G1 
69.83 
±3.84 
4.38 
±0.55 
6.10 
±0.67 
3.28 
±0.55 
0.81 
±0.06 
15.25 
±1.49 
32.48 
±2.24 
G2 
156.33 
±7.25
**(a)
 
1.30 
±0.23
**(a)
 
19.03 
±1.55
**(a)
 
13.55 
±1.29
**(a)
 
1.75 
±0.20
**(a)
 
47.15 
±4.45
**(a)
 
75.58 
±4.11
**(a)
 
G3 
76.89± 
2.89
**(b)
 
3.25± 
0.67
**(b)
 
7.58± 
0.63
**(b)
 
5.10± 
0.87
**(b)
 
0.88± 
0.07
**(b)
 
19.32± 
1.98
**(b)
 
35.62± 
2.32
**(b)
 
G4 
86.63 
±3.65
**(b)
 
2.95 
±0.35
**(b)
 
9.52 
±0.45
**(b)
 
7.92 
±0.74
**(b)
 
0.95 
±0.09
**(b)
 
24.05 
±2.65
**(b)
 
40.25 
±2.75
**(b)
 
 
 
• Values are expressed as Mean± SEM 
• Values were find out by using ONE WAY ANOVA Followed by  Newman keul’s 
multiple range test 
• **(a)values were significantly different from normal control G1 at P< 0.01 
• **(b) values were significantly different from Lithiatic control G2 at P<0.01 
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TABLE 3: EFFECT OF ARUVAGAI CHOORANAM  AND CYSTONE ON SERUM 
PARAMETERS IN PROPHYLACTIC TREATMENT OF ANIMALS 
GP 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl) 
Uric acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
G1 
4.73 
±0.68 
9.36 
±1.24 
3.45 
±0.40 
0.56 
±0.06 
6.6 
±0.57 
12.06 
±1.43 
G2 
1.26 
±0.36
**(a)
 
18.05 
±2.42
**(a)
 
9.7 
±1.10
**(a)
 
1.01 
±0.13
**(a)
 
12.60 
±1.61
**(a)
 
26.01 
±3.25
**(a)
 
G3 
4.10± 
0.54
**(b)
 
10.74± 
1.34
**(b)
 
3.90± 
0.54
**(b)
 
0.68± 
0.08
**(b)
 
7.23± 
0.12
**(b)
 
16.29± 
0.87
**(b)
 
G4 
3.42 
±0.42
**(b)
 
12.26 
±1.42
**(b)
 
4.40 
±0.55
**(b)
 
0.82 
±0.10
**(b)
 
8.05 
±0.65
**(b)
 
21.05 
±2.12
**(b)
 
 
 
• Values are expressed as Mean± SEM 
• Values were find out by using ONE WAY ANOVA Followed by  Newman keul’s 
multiple range test 
• **(a)values were significantly different from normal control G1 at P< 0.01 
• **(b) values were significantly different from Lithiatic control G2 at P<0.01 
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TABLE 4: EFFECT OF ARUVAGAI CHOORANAM  AND CYSTONE ON URINARY 
BIOCHEMICAL PARAMETERS IN CURATIVE TREATMENT OF ANIMALS 
GP 
Protein 
(mg/dl) 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl) 
Uric acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
G1 
73.45 
±3.84 
4.66 
±0.72 
6.40 
±0.65 
3.80 
±0.78 
14.95 
±2.15 
19.21 
±1.76 
35.05 
±2.90 
G2 
170.83 
±7.97
**(a)
 
1.51 
±0.22
**(a)
 
17.96 
±2.11
**(a)
 
15.00 
±2.52
**(a)
 
81.88 
±4.14
**(a)
 
49.98 
±3.45
**(a)
 
80.28 
±4.75
**(a)
 
G3 
80.34± 
2.98
**(b)
 
4.03± 
0.38
**(b)
 
7.87± 
0.88
**(b)
 
5.10± 
0.56
**(b)
 
25.63± 
2.67
**(b)
 
22.95± 
2.54
**(b)
 
38.43± 
2.03
**(b)
 
G4 
90.66 
±3.82
**(b)
 
3.50 
±0.45
**(b)
 
10.28 
±1.05
**(b)
 
8.6 
±1.08
**(b)
 
32.93 
±3.30
**(b)
 
26.05 
±2.25
**(b)
 
41.33 
±2.83
**(b)
 
 
• Values are expressed as Mean± SEM 
• Values were find out by using ONE WAY ANOVA Followed by  Newman keul’s 
multiple range test 
• **(a)values were significantly different from normal control G1 at P< 0.01 
• **(b) values were significantly different from Lithiatic control G2 at P<0.01 
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TABLE 5: EFFECT ARUVAGAI CHOORANAM  AND CYSTONE ON SERUM 
PARAMETERS IN CURATIVE TREATMENT OF ANIMALS 
GP 
Magnesium 
(mg/dl) 
Calcium 
(mg/dl) 
Uric acid 
(mg/dl) 
Creatinine 
(mg/dl) 
Oxalate 
(mg/dl) 
Phosphate 
(mg/dl) 
G1 
5.16 
±0.92 
10.38 
±1.29 
4.12 
±0.89 
0.98 
±0.19 
8.8 
±0.96 
15.62 
±2.01 
G2 
1.92 
±0.48
**(a)
 
24.06 
±2.42
**(a)
 
12.06 
±2.38
**(a)
 
2.82 
±0.62
**(a)
 
17.46 
±1.20
**(a)
 
29.90 
±3.06
**(a)
 
G3 
4.76± 
0.83
**(b)
 
11.89± 
1.34
**(b)
 
5.43± 
0.90
**(b)
 
1.10± 
0.22
**(b)
 
9.78± 
1.08
**(b)
 
16.48± 
2.10
**(b)
 
G4 
4.05 
±0.79
**(b)
 
13.36 
±1.10
**(b)
 
6.65 
±0.95
**(b)
 
1.39 
±0.45
**(b)
 
10.53 
±1.10
**(b)
 
17.03 
±2.42
**(b)
 
 
 
• Values are expressed as Mean± SEM 
• Values were find out by using ONE WAY ANOVA Followed by  Newman keul’s 
multiple range test 
• **(a)values were significantly different from normal control G1 at P< 0.01 
• **(b) values were significantly different from Lithiatic control G2 at P<0.01 
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Annexure - II 
BIO-CHEMICAL ANALYSIS 
BIOCHEMICAL ANALYSIS OF ARUVAGAI CHOORANAM 
Preparation of the extract 
 5 gm of the drug was weighed accurately and placed in a 250ml clean beaker. 
Then, 50 ml distilled water was added and dissolved well. It was boiled well for about 
10 minutes. Later, it was cooled and filtered in a 100 ml volumetric flask and  it was 
made up to 100 ml with distilled water. This fluid was taken for analysis. 
Qualitative Analysis 
QUALITATIVE ANALYSIS 
S.No EXPERIMENT OBSERVATION INFERENCE 
1. TEST FOR CALCIUM 
 2ml of the above  prepared  A white  Indicates    
 extract is  taken in a clean test  precipitate   presence of    
 tube. To this 2ml of  4%  formed. Calcium  
 Ammonium oxalate   
 solution. 
2. TEST FOR SULPHATE 
 2ml of the extract is added  No white  Absence  
 to 5% Barium chloride solution. precipitate   is  of  
  formed.   Sulphate 
3. TEST FOR CHLORIDE A white Indicates 
 The extract is treated  precipitate Presence of 
 with Silver nitrate  solution.  is formed. Chloride. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
4. TEST FOR CARBONATE  
 The extract is treated No brisk Absence 
 with concentrated effervessence  of  
 Hydrochloric Acid. formed. Carbonate. 
5. TEST FOR STARCH   
 The extract is added with  No Blue colour Absence of 
 weak Iodine  is formed. Starch. 
 solution. 
6. TEST FOR IRON Ferric 
 The extract is  treated with  No Blue colour Absence of  
 Glacial acetic acid and  is formed. Ferric Iron. 
 Potassium ferrocyanide   
7. TEST FOR IRON  Ferrous  Indicates the  
 The extract is treated with  Blood red  presence of  
 concentrated Nitric acid and  colour   is formed. Ferrous Iron. 
 Ammonium  thiocyanate solution.    
8. TEST FOR PHOSPHATE 
 The extract is treated No yellow Absence 
 with Ammonium  molybdate  precipitate is of 
 and  conc. Nitric acid. formed. Phosphate. 
9. TEST FOR ALBUMIN 
 The extract is treated No yellow Absence 
 with  Esbach’s reagent. precipitate  is formed. of Albumin. 
10. TEST FOR TANNIC ACID 
 The extract is  treated   No Blue black Absence 
 with Ferric  chloride precipitate  is formed. of       
   Tannic acid. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
11. TEST  FOR UNSATURATION  
 Potassium permanganate It does not Absence of 
 solution is added to the decolourisation. unsaturated   
 little of the extract.  compounds 
    
12. TEST  FOR REDUCING 
 SUGAR 
 5ml of Benedict’s  quantitative  No Colour change Absence  
  solution is taken in a test tube   occured. of  
  and allowed to boil for  2 minutes     Reducing sugar. 
  and 8-10 drops  of the extract     
 is added and boiled  again for  
 2 minutes. 
13. TEST FOR AMINO ACID 
 One or two drops of the extract  No Violet colour is  Absence of 
 is placed on a filter paper and   formed. Amino acid 
 dried well. After drying 1%    .   
 Ninhydrin is sprayed  over the  
 same and dried well. 
14. TEST FOR ZINC 
 The extract is treated with No white precipitate Absence 
 Pottasium Ferrocyanide is formed of Zinc 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
POST-GRADUATE DEPARTMENT OF POTHU MARUTHUVAM 
AN OPEN CLINICAL TRIAL OF “ARUVAGAI CHOORANAM” (INTERNAL) FOR “KALLADAIPPU 
(UROLITHIASIS)”  
FORM: I - SCREENING FORM 
..1. Sl. No :  2. OP / IP No  :  ..3.
 Bed No :  4. Name  :  ..5.
 Age :  6. Gender :  ..7.
 Postal Address : 
I. INCLUSION CRITERIA 
   Specific Criteria 
1. Age: 25 – 75 Years 
2. Gender: Both Male and Female 
3. Colicky pain: Loin / Groin, Loin to Groin 
4. Haematuria 
5. Pyuria 
6. Dysuria 
7. Oliguria 
   Non-specific Criteria 
1. Diabetes mellitus 
2. Systemic Hypertension 
3. Crystaluria 
II. EXCLUSION CRITERIA 
1. Subacute appendicitis 
2. Cholecystitis 
3. Amoebic colitis 
4. Pyelonephritis 
5. Perinephric abscess 
6. Cystitis and UTI 
7. Sexually transmitted disease 
8. Pelvic inflammatory disease 
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9. Post-renal azotemia 
10. Obstructive uropathy 
 
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
 
POST-GRADUATE DEPARTMENT OF POTHU MARUTHUVAM 
 
AN OPEN CLINICAL TRIAL OF “ARUVAGAI CHOORANAM” (INTERNAL) FOR “KALLADAIPPU 
(UROLITHIASIS)”  
 
FORM: II - CONSENT FORM 
CERTIFICATE BY INVESTIGATOR 
I certify that I have disclosed all the details about the study in the terms  readily 
understood by the patient.  
 
Date: …………….      Signature:  ………….………..  
 
CONSENT BY PATIENT 
I have been informed to my satisfaction, by the attending physician, the purpose of the clinical trial, and the 
nature of drug treatment and follow-up including the laboratory investigations to be performed to monitor and 
safeguard my body functions. 
I am aware of my right to opt out of the trial at any time during the course of the trial without having to give 
the reasons for doing so. 
I, exercising my free power of choice, hereby give my consent to be included as a subject in the clinical trial 
for the disease “Kalladaippu” using the siddha drugs “Aruvagai Chooranam”  
(internal).  
      
 Signature :……………………..…….. 
   
Date : ……………. Name :…………………....……… 
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AWã ºjR UìjçYd LpÛÃ Utñm UìjçYUû] 
Tôû[VeúLôhûP 
ThP úUtT¼lé ùTôç UìjçYjçû\ 
LpXûPlé úSôndá UìkRôL AñYûLf ÑWQm TÃLÃléj¾\û]d LiPÈëm 
UìjçY Bnî 
JléRp T¼Ym 
BnYô[Wôp Nôu\ÇdLlThPç. 
 
 Sôu CkR Bnî áÈjR Aû]jç ÅTWeLû[ëm úSôVôÇdá éÃëm YûLÂp 
GåjçûWjúRu G] Eñ¾VÇd¸ú\u. 
 
úR¾ :      ûLùVôlTm ............................. 
CPm :      ùTVo ....................................... 
 
úSôVôÇÂu JléRp 
 GuÉPm CkR UìjçY BnÅu LôWQjûRëm Uìk¾u RuûU Utñm UìjçY 
YÆêû\ûVl TtÈëm ùRôPokç G]ç EPp CVdLjûR LiLô½dLîm, ARû]l 
TôçLôdLîm TVuTåm UìjçY BnîdÏP TÃúNôRû]Ls TtÈ ¾ìl¾ AÇdám 
YûLÂp Bnî UìjçYWôp Å[d¸d Ï\lThPç. 
 Sôu CkR UìjçY BnÅuúTôç LôWQm Gçîm Ï\ôUp GlùTôïç 
úYiåUô]ôím CkR BnÅÄìkç Guû] ÅåÅjçd ùLôsðm EÃûUûV 
ùRÃk¾ìd¸ú\u. 
 Sôu GuòûPV ãRk¾WUôL úRoî ùNnëm EÃûUûVd ùLôiå LpXûPlé 
úSôndá UìkRôL AñYûLNó ÑWQm TÃLÃléj¾\û]d LiPÈëm UìjçY BnÅtá 
Guû] EhTåjR JléRp AÇd¸ú\u. 
 
úR¾ :      ûLùVôlTm ............................. 
CPm :       ùTVo ....................................... 
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GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
PALAYAMKOTTAI, TIRUNELVELI DISTRICT 
 
POST-GRADUATE DEPARTMENT OF POTHU MARUTHUVAM 
 
AN OPEN CLINICAL TRIAL OF “ARUVAGAI CHOORANAM” (INTERNAL) FOR “KALLADAIPPU 
(UROLITHIASIS)”  
 
FORM: III – CASE SHEET PROFORMA (OP & IP) 
 
1. Sl. No :  2. OP/IP No  :  
3. Bed No :  4. Name  :  
5. Age :  6. Gender :  
7. Nationality :  8. Religion :  
9. Occupation :  10. Socio-economic Status :  
11. Postal Address : 
 
 
   
12. Date of   13. Date of     
 Admission :   Discharge :    
14. Number of days  
 treated 
    
15. Result : GOOD / FAIR / 16. Diagnosis :   
   POOR    
 
 
 
Medical Officer 
 
 
 
17. COMPLAINTS & DURATION:     
 
    
 
 
18. HISTORY OF PRESENT ILLNESS: 
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19. PAST HISTORY :  YES NO 
  Hypertension :   
  Diabetes mellitus :   
  Renal calculi :   
  Ureteric  obstruction :    
  Prolonged immobilization :   
  Renal tuberculosis :   
  Amyloidosis  :   
 ENDOCRINE DISORDERS :  
  Hyperparathyroidism :    
  Cushing syndrome :   
 CONGENITAL DISORDER HISTORY : YES NO 
  Medullary spongy kidney :   
  Myelo proliferative disorder :   
 TREATMENT HISTORY : 
  Oral diuretics :   
  Non-steroid anti-inflammatory drugs :   
  Surgery for urinary calculus :   
  Extra corporeal shockwave lithotripsy :    
20. FAMILY HISTORY : 
  Gout :    
  Cystinuria :   
  Xanthinuria :   
21. HABITS : 
 DIET HISTORY : 
  Vegetarian foods :    
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 High intake of dairy products :   
 Low calcium diet :   
  Nuts :    
  Non-vegetarian foods :   
  Meat :   
  Poultry :   
  Fish :    
       Drinks / Tobacco & Betel chewing / Smoking: 
 Alcohol :    
 Tea :   
 Coffee :   
 Milk :   
 Smoking :   
 Tobacco chewing :   
 Betel chewing :   
22. PERSONAL HISTORY : 
 
 
 
 
23. GENERAL EXAMINATIONS 
 a) Consciousness :   
 b) Orientation :   
 c) Decubitus :   
 d) Body weight (Kg) :   
 e) Height (cm) :   
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